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Abstract
The problem of co-occurring substance abuse and mental health disorders among the
veteran population can impact numerous aspects of a veteran’s life, including selfesteem, relationships, employment, and legal issues. The Mental Health Residential
Rehabilitation Treatment Program (MH RRTP) at the Saint Cloud, Minnesota VA
Healthcare System is a program that provides residential treatment for this population.
Identifying practical and beneficial treatment methods promotes better coping
mechanisms for veterans and impacts social change by providing timely and costefficient care for veterans, while also leading the way for overall changes and
improvements in other VA residential treatment programs. This study identified how
using the integrated treatment model in the MH RRTP impacted depression, anxiety, and
sobriety protective factors among 1,136 veterans who completed the program between
2016 and 2017, and if there were any significant differences in outcomes among various
age groups and lengths of stay in the program. Outcome measures taken at pre and post
treatment, using BDI-II, BAI, and BAM, were analyzed by using six one-within onebetween (mixed-model) Analysis of Variance (ANOVA) tests. Significant interaction
effects were noted for protective factors in length of stay and age group categories and
for depression and length of stay. Significant main effects for within-subjects factors
were consistently noted for all categories, indicating a reduction in depression and
anxiety symptoms, while increasing protective factors for the veterans in this study. The
results demonstrated that veterans responded favorably without regard to potential
differences in age groups and lengths of stay.
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Chapter 1: Nature of the Study
Introduction
Co-occurring disorders, sometimes described as dual diagnosis or comorbidity,
refers to an individual having both a substance use disorder (abuse or dependence) and a
mental health diagnosis that can be considered independent of each other (Substance
Abuse and Mental Health Services Administration [SAMHSA], 2009). Studies have
shown a high rate of comorbid substance abuse with psychiatric diagnoses including
bipolar disorder, depression, anxiety disorders, psychosis, and antisocial and borderline
personality disorders (Kelly & Daley, 2013). One of the most significant challenges for
recovery from both types of disorders is relapse, which for substance abuse would
constitute resuming use of a substance after remission and for mental health disorders
would involve experiencing an increase of symptoms after a period of greater
manageability (Decker, Peglow, Samples, & Cunningham, 2017; Reif et al., 2014).
Recovery is described by SAMHSA (2009) as engaging in a process, often over a
long term, that focuses on internal change. To prevent relapse or increase the probability
of maintaining recovery, it is important to have available treatments that provide a greater
likelihood of symptom management, sobriety, and life satisfaction. Recovery-oriented
approaches tend to emphasize the strengths and needs of the individual, rather than
focusing entirely on the traditional “disease model” (Frost et al., 2017). Intervention
approaches include motivational interviewing, harm reduction models for substance
abuse, cognitive behavioral therapy, medications, and self-help therapies (Merrill &
Duncan, 2014) or a combination of these modalities. There are various treatment
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programs available, including programs for the veteran population, but there are
questions about which provide a greater level of effectiveness. One of these treatments is
residential programming, which consists of patients living onsite while receiving
therapeutic interventions daily for an agreed-upon time frame. Within the Veterans
Affairs (VA) Healthcare System, these programs are referred to as Mental Health
Residential Rehabilitation Treatment Programs.
Problem Statement
The VA Healthcare System treats a variety of mental health and substance abuse
concerns among military veterans, with treatment taking place in outpatient, inpatient, or
residential settings. There are approximately 21 million veterans in the United States, and
nearly 50% receive care through the VA, with the projected rate of those receiving
mental health care expected to increase significantly over the next decade (Department of
Veterans Affairs, 2016).
The increasing number of veterans receiving mental health care highlights the
importance of identifying beneficial treatment options within the VA system (Kelly &
Daley, 2013). When mental health symptoms are untreated, veterans are impacted in
many areas, including family relationships, work functioning, self-esteem, and overall
ability to cope (Karlin et al., 2012; McHugh, 2015). There is limited literature regarding
residential VA programs focusing on treatment for veterans of all ages and eras who
report difficulty with co-occurring disorders (Vest et al., 2014), which involve the
presence of both a substance use disorder and a mental health problem such as
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depression, posttraumatic stress disorder (PTSD) and other anxiety disorders, psychosis,
or bipolar disorder.
The information acquired from this exploratory study adds to the currently limited
body of knowledge on residential VA programs that treat co-occurring disorders such as
depression, anxiety, and various forms of substance abuse. It also provides crucial
information on the effectiveness of the integrated treatment model, which SAMHSA
(2009) describes as using a variety of therapeutic interventions to allow it to be more
individualized.
The Mental Health Residential Rehabilitation Treatment Program (MH RRTP) at
the Saint Cloud VA Healthcare System in Minnesota has historically had two main
tracks: the PTSD track (16 of 148 beds) and the co-occurring disorders (COD) track (the
remaining 132 beds), which provides treatment to veterans with co-occurring mental
health and substance use disorders. Notably, the PTSD and COD tracks were recently
merged in 2018. However, until 2018, there were some veterans who chose to complete
the COD track and then go on further to the PTSD track, which was a more intensive
cognitive-processing program specific to PTSD. This study, however, focused solely on
the co-occurring disorders track, which treats many mental health problems, including
bipolar disorder, anxiety disorders, PTSD, and depression, in addition to substance use
disorders. There are currently no published studies concerning treatment outcomes of the
co-occurring disorders track at the Saint Cloud VA and very few about other VA cooccurring disorders residential programs or use of the integrated treatment model with
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veterans. It is vital to establish whether current treatment interventions are benefitting the
veteran population and to make positive changes in programming as necessary.
Purpose of the Study
The purpose of this study was to examine outcomes based on use of the integrated
treatment model in the MH RRTP (SAMHSA, 2009). Secondary data that included selfreport scores collected at the beginning and end of treatment from the Beck Depression
Inventory-II, Beck Anxiety Inventory, and Brief Addiction Monitor were compared to
determine the effectiveness of the service delivery model of MH RRTP. This was
accomplished by analyzing secondary data to determine general program effectiveness of
the integrated treatment model as it was used in MH RRTP and to specifically identify
outcomes regarding length of stay differences. Comparisons in outcomes were made for
veterans who participated in a brief treatment episode of care (33 days or less), a
moderate time frame (34-46 days), and a longer program (47 or more days). An
additional component of this purpose was to determine potential outcome differences
among age groups. The outcome data for the age groups 21-30 years, 31-40 years, 41-50
years, 51-60 years, and over 60 years were compared. These age groups were chosen
based on developmental stages and the ages of veterans who typically present to MH
RRTP for treatment. This exploratory study provides general information that will allow
for future studies to determine outcomes related to specific interventions, differences for
males versus females, differences in outcomes for individuals with specific diagnoses,
and long-term prognosis for participants of the program.
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Research Questions and Hypotheses
There are unanswered questions related to how residential treatment may benefit
the general veteran population in reducing depression and anxiety, whether there are
differences among the various age groups served, and whether length of stay significantly
impacts symptom reduction. These questions and concerns guided the research questions
and hypotheses for this MH RRTP study:
Research Question 1: Are there differences in veterans’ outcomes for overall
depression symptoms from pre and post treatment based on length of stay (33 or fewer
days, 34-46 days, and 47 or more days) in MH RRTP?
H01:

There is no statistically significant difference in veterans’ outcomes for
overall depression symptoms from the start of treatment to completion
based on length of stay (33 or fewer days, 34-46 days, and 47 or more
days) in MH RRTP.

HA1: There is a statistically significant difference in veterans’ outcomes for
overall depression symptoms from the start of treatment to completion
based on length of stay (33 or fewer days, 34-46 days, and 47 or more
days) in MH RRTP.
Research Question 2: Are there differences in veterans’ outcomes for overall
anxiety symptoms from pre and post treatment based on length of stay (33 or fewer days,
34-46 days, and 47 or more days) in MH RRTP?
H02:

There is no statistically significant difference in veterans’ outcomes for
overall anxiety symptoms from the start of treatment to completion based
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on length of stay (33 or fewer days, 34-46 days, and 47 or more days) in
MH RRTP.
HA2: There is a statistically significant difference in veterans’ outcomes for
overall anxiety symptoms from the start of treatment to completion based
on length of stay (33 or fewer days, 34-46 days, and 47 or more days) in
MH RRTP.
Research Question 3: Are there differences in veterans’ protective factors scores
from pre and post treatment based on veterans’ length of stay?
H03:

There is no statistically significant difference in veterans’ protective
factors scores from pre and post treatment based on veterans’ length of
stay.

HA3: There is a statistically significant difference in veterans’ protective factors
scores from pre and post treatment based on veterans’ length of stay.
Research Question 4: Are there differences in veterans’ outcomes for overall
depression symptoms from pre and post treatment based on veterans’ age groups?
H04:

There is no statistically significant difference in veterans’ outcomes for
overall depression symptoms from pre and post treatment based on
veterans’ age groups.

HA4: There is a statistically significant difference in veterans’ outcomes for
overall depression symptoms from pre and post treatment based on
veterans’ age groups.
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Research Question 5: Are there differences in veterans’ outcomes for overall
anxiety symptoms from pre and post treatment based on veterans’ age groups?
H05:

There is no statistically significant difference in veterans’ outcomes for
overall anxiety symptoms from pre and post treatment based on veterans’
age groups.

HA5: There is a statistically significant difference in veterans’ outcomes for
overall anxiety symptoms from pre and post treatment based on veterans’
age groups.
Research Question 6: Are there differences in veterans’ protective factors scores
from pre and post treatment based on veterans’ age groups?
H06:

There is no statistically significant difference in veterans’ protective
factors scores from pre and post treatment based on veterans’ age groups.

HA6: There is a statistically significant difference in veterans’ protective factors
scores from pre and post treatment based on veterans’ age groups.
Theoretical Framework
This study was based primarily on the integrated treatment model, which
SAMHSA (2009) describes as having several key elements: concurrent treatments for
mental health and substance abuse concerns, medication management, motivational and
cognitive-behavioral interventions, and multiple formats, including group, family, and
individual therapies. This theoretical framework encompasses several theories and
interventions, including the transtheoretical model, which uses circular questioning and a
“stages of change” approach. Within this model, there is a progression of behavior and
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motivation changes, with stages including precontemplation, contemplation, preparation,
action, and maintenance (Norcross, Krebs, & Prochaska, 2011). The clinician uses
statements and questions that are thought to assist with self-motivation (Moyers &
Houck, 2011).
Additionally, cognitive and behavioral theories are driving forces in the integrated
treatment model. Cognitive theory “postulates that we develop habits of thinking that
form the basis for our screening and coding of environmental input, categorizing and
evaluating that experience, and making judgments about how to behave” (Walsh, 2010, p.
148). The theory asserts that individuals have thought patterns and core beliefs that
influence the processing, assimilation, and accommodation of information (Walsh, 2010).
Behavior theory emphasizes learning principles, such as classical conditioning, operant
conditioning, and modeling behavior (Walsh, 2010).
Study Approach
A descriptive quantitative retrospective study was conducted to analyze scores
from the Beck Depression Inventory II (BDI-II), Beck Anxiety Inventory (BAI), and
Brief Addiction Monitor (BAM) by using secondary data. These tools are used at the
beginning and end of treatment for veterans who complete a residential program (typical
stay is between 27-60 days) and provide a thorough comparison of symptoms prior to and
upon completing treatment, as well as the stage of change (precontemplation,
contemplation, preparation, and action/maintenance) of the veteran’s recovery. In this
study, the independent variables were the ages of the veterans and the length of stay in
treatment, and the dependent variables were the scores from the BDI-II and BAI, as well
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as protective factors scores from the BAM. The length of stay groups included veterans
who stayed 33 or fewer days, 34-46 days, and more than 46 days. These intervals were
selected because they reflected the most common lengths of stay in MH RRTP. The MH
RRTP study age ranges were divided as follows: 21-30 years, 31-40 years, 41-50 years,
51-60 years, and 61 years and over.
Random assignment was not feasible for this study, as all veterans who were
accepted into MH RRTP were treated in the program, as opposed to some individuals
being assigned to other treatment protocols such as outpatient programs. Analysis of
variance (ANOVA) tests were conducted to compare pre and posttest means within the
age and length of stay groups for the BDI-II, BAI, and BAM protective factors.
Definition of Terms
The following are definitions for key concepts in this study:
Co-occurring disorder: This term refers to the presence of at least one substance
use disorder diagnosis along with at least one mental health disorder diagnosis. Another
term that may be used interchangeably is comorbidity.
Dual diagnosis: This term is sometimes used interchangeably with co-occurring
disorder.
Mental Health Residential Rehabilitation Treatment Facility (MH RRTP): A
treatment facility in which the participants reside onsite while receiving daily
interventions for their diagnoses, whether substance use, mental health, or co-occurring
disorders. In this study, MH RRTP refers specifically to the Mental Health Residential
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Rehabilitation Treatment Facility at the Saint Cloud VA Healthcare System, which is part
of the Veterans Healthcare System (also referred to as VA).
Participants: The participants in this study were veterans who had participated in
the MH RRTP at the Saint Cloud Healthcare System.
Substance use disorder: This term refers to the diagnosis of either substance abuse
or dependence.
Veteran: This term refers to any individual who served for any length of time in a
U.S. military service branch.
Veterans Affairs (VA)/Veterans Health Administration (VHA)/Veterans Affairs
Healthcare System (VAHCS): These terms are often used interchangeably to describe the
agency that provides healthcare and mental health services to the veteran population.
Length of stay: The number of days that a veteran resided in the MH RRTP. It is
important to note that this is determined by the veteran him- or herself at admission (in
the first few days after arriving) to the program. The protocol of choosing the length of
stay is based on the veterans’ preference and the need to have a discharge date in place.
This also allows for other veterans to plan for admission (with a concrete date) to the
program.
Assumptions
In this study it was assumed that the participants (veterans) answered honestly on
the subjective scale questionnaires that they completed at admission and discharge from
the treatment program. It was also assumed that the veteran sample was representative of
the population of veterans who have experienced co-occurring disorders with moderate to
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severe depression and/or anxiety symptoms, strengthened by the large sample in this
study. Lastly, it was assumed that all veteran data were entered correctly by the MH
RRTP staff.
Delimitations
The boundaries of this study were provided by several delimitations. The
participants in this study were all adult veterans who had made the decision to enter MH
RRTP for treatment of mental health and/or substance abuse disorders. Veterans may
present to the Saint Cloud MH RRTP from various areas in the United States, but they
are typically from communities around the Midwest area due to the location of the
program. The veterans in this study were admitted to the program between January 1,
2016 and December 31, 2017 and discharged with “regular status,” which is the term
used to describe veterans who have successfully completed the program. Those
discharged as “irregular status” were not included in the study, primarily due to these
individuals not completing both the pre and posttests included in the study and leaving
prior to their planned discharge date. Additionally, because one of the variables was
length of stay, which was largely influenced by the veteran’s choice, it would have been
contradictory to include these individuals, in that they did not complete their initial length
of stay request. As noted previously, due to a robust sample size, it is likely that the
results are generalizable to members of the veteran population who have been diagnosed
with co-occurring disorders and seek treatment in VA residential settings.
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Limitations
There are general limitations to external validity in this study. These primarily
involve lack of generalizability to the larger population. The results of this study only
apply to veterans with co-occurring disorders who participate in residential treatment
within the VA system and report difficulty with depression and/or anxiety symptoms.
Because this study used a descriptive quantitative retrospective design involving
secondary data, a true cause and effect cannot be established, in that it was not possible to
manipulate the variables in this study. While the study does not allow for overall
generalizability to the entire population, it can provide key information about the
program’s effectiveness for the veterans who have participated in the program.
There are several internal validity limitations that must also be considered for this
study. The first is related to fidelity of the interventions. The MH RRTP clinicians were
trained to facilitate the core groups of cognitive behavioral therapy (CBT) and stages of
change/motivational interviewing (SCMI) in a similar manner, with the material being
consistent in all groups, but personality and therapeutic styles may have impacted the
outcomes to a certain extent. Additionally, while all veterans in MH RRTP received the
core groups of SCMI and CBT, there were elective groups that some attended, which
focused on other areas of concern, such as guilt/shame issues, emotions, and
relationships. Therefore, this study was exploratory and focused primarily on the overall
outcomes of participating in and completing the program. Additional limitations included
not examining long-term treatment outcomes of MH RRTP, instead focusing specifically
on treatment impact at program completion. Future studies may investigate outcome
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differences based on the selection of elective groups, as well as differences among the
MH RRTP teams (which are based on diagnosis and severity of symptoms), types of
substances abused, outcome differences by gender and ethnicity/race, and long-term
effects. Moreover, there was the risk of social desirability bias, a type of response that
occurs when participants answer questions on self-report questionnaires in a way that
makes them appear to be functioning better than they really are. However, this often
occurs when participants are actively involved in a research study and may be less likely
with archival data. Further, there was the potential for attrition bias (Salkind, 2010), in
that individuals who did not complete both the pretest and posttest for the depression,
anxiety, and substance abuse measures were not included in the study. It would be
beneficial for future studies to examine potential reasons for not completing the posttest
questionnaires. Veterans may have preferred not to answer the questions, missed the
outcome group (completed close to discharge), or left the program due to an irregular
discharge. Investigating the reasons behind irregular discharges in future studies might
also provide useful information.
Finally, a limitation that should be considered relates to the potential for
depression symptoms decreasing due to the duration of sustained abstinence during
residential treatment. This has been studied in previous research, including via a metaanalysis of 22 studies from 1980 to 2014 (Foulds, Adamson, Boden, Williman, &
Mulder, 2015). Although there is sometimes an increase in depression symptoms during
early withdrawal, this meta-analysis demonstrated that there may be a correlation
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between symptoms and duration of sobriety, often during the first 3 to 6 weeks of
treatment (Foulds et al., 2015).
Significance of the Study
Mental health care access in the United States has become increasingly limited
over the last 20 years, including for the population of veterans (Blais, Tsai, Southwick, &
Pietrzak, 2015), partly due to perceptions of stigma, cost, and lack of insurance (Rowan,
McAlpine, & Blewett, 2013). This lack of access has contributed to an increase in
financial and legal difficulties, as well as relapse, family relationships, and societal
problems, such as higher crime rates associated with behavioral aspects of substance
abuse (Brorson, Arnevik, Rand-Hendriksen, & Duckert, 2013). Due to comorbidity of
mental health and substance abuse disorders appearing to be prevalent among veterans,
increased understanding of helpful methods of treatment is crucial (Kelly & Daley,
2013). Identifying the outcomes of MH RRTP is beneficial in increasing understanding
of both strengths and limitations of the residential program (Brorson et al., 2013; Reif et
al., 2014), as well as the effectiveness of the integrated treatment model with the veteran
population and determining differences in outcomes among age groups and the number of
days completed in treatment. This information may provide a wealth of knowledge for
improving the MH RRTP and the numerous other programs at various VA facilities in the
United States, thereby having the potential to positively impact thousands of veterans.
The MH RRTP is a unique program and is being used as an example among several other
residential programs in the VA system, many of which do not use the integrated
treatment model, thus illustrating the crucial nature of determining program effectiveness.
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Summary
This is one of few studies that has focused on a residential program for cooccurring disorders in the Veterans Healthcare Administration. While there have been
numerous studies that have focused primarily on PTSD, very few have investigated cooccurring disorders that encompass a variety of co-occurring conditions including PTSD,
depression, schizophrenia, anxiety, and bipolar disorder in addition to substance abuse.
This study has provided crucial information in learning about the types of treatment that
may be beneficial to veterans with co-occurring disorders, particularly with the presence
of depression and anxiety, and the role of residential treatment for these individuals.

16
Chapter 2: Literature Review
Introduction
To have a clearer understanding of co-occurring disorders among veterans and
programs available in the VA system, it is important to consider several aspects of
working with this population. The military has a unique culture that significantly differs
from civilian culture and carries over after an individual has left the military. Within the
culture of veterans are several subcultures and noteworthy characteristics that are critical
to remember when providing clinical services. Additionally, there are complex
relationships between veterans with co-occurring disorders and suicide rates, as well as
homelessness, chronic pain, traumatic brain injury (TBI), military sexual trauma (MST),
and involvement in the criminal justice system (Castro & Kintzle, 2014; Crane, Schlauch,
& Easton, 2015; Gilmore et al., 2016; Yoon, Petrakis, & Rosenheck, 2015).
Residential programming can offer advantages not found in other settings such as
an outpatient clinic, which may include structure, recovery-based activities, and housing,
while not being as authoritarian as an inpatient unit (Reif et al., 2014). Veterans using the
Saint Cloud MH RRTP experience privileges, in that they are able to leave the residential
unit while staying within the 200-acre VA campus and neighboring baseball field and VA
golf course; after a few weeks, they have the possibility of taking therapeutic passes offgrounds. This can provide an opportunity to practice the skills learned in MH RRTP and
then return to programming to process the experience. Veterans often report that this
structure is beneficial in gaining more confidence and becoming more prepared overall
for independence after treatment completion.
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Relapse has traditionally been a concern of individuals who participate in any
type of substance abuse or co-occurring disorders treatment program, as well as of staff
who provide such interventions. While relapse remains a concern after individuals
complete a residential program, studies have demonstrated that for those who leave
treatment without “successful completion,” there may be exacerbation of symptoms and
difficulty maintaining motivation for recovery (Brorson, Arnevik, Rand-Hendriksen, &
Duckert, 2013; Decker, Peglow, Samples, & Cunningham, 2017; Reif et al., 2014). Thus,
it is imperative that a program offer the needed interventions and stability to assist an
individual with continuing to work on maintaining a recovery-oriented attitude, which is
what the MH RRTP strives to provide.
Literature Search Strategies
The following key words and combinations of these words were used for
searching the literature: veterans, substance abuse, mental health, depression, anxiety,
co-occurring disorders, residential treatment, integrated dual diagnosis treatment,
motivational interviewing, cognitive behavioral therapy, and integrated treatment model.
The databases and portals used to search for the previously mentioned key words were
EBSCO, Thoreau, Google Scholar, and Science Direct. All databases offered by the
portals were selected to elicit as many responses as possible.
Lack of Research on Veterans With Co-occurring Disorders
There has been a lack of research on residential programs that treat veterans with
co-occurring disorders. Numerous studies have focused on residential treatment for
veterans with PTSD and those with both PTSD and co-occurring substance abuse
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disorders. However, very few studies have investigated co-occurring disorders among
veterans who have other or additional problems, such as depression, generalized anxiety,
bipolar disorder, and schizophrenia. The veterans in the MH RRTP present with a variety
of diagnoses, including psychosis, depressive disorders, and various anxiety disorders,
along with substance abuse or dependence.
Military Culture
The military has a culture of its own, and it is important to recognize and honor
this when working with military veterans. The reasoning behind joining the military
varies among individuals, but Hall (2011) described four main reasons: family tradition,
escape, the benefits available, and identification as a “warrior.” There are families with a
tradition of joining the military, which confers a certain pride, leading to individuals
enlisting. For other individuals, there are benefits, such as those provided under the GI
bill, that can help those coming from lower income homes to go to school or otherwise
better their lives (Hall, 2011). A “warrior” mentality is another potential reason for
joining the military, which encompasses a purpose of protecting others and may be highly
important to individuals (Meyer & Wynn, 2018). Finally, some military personnel
determined that their life situation was dire enough that the military provided hope and a
chance for a better future (Hall, 2011); such personnel may find within the military a
family, something unavailable to them while growing up. There are various other reasons
for joining the military, but these four are thought to be the most common (Hall, 2011).
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Veterans
A veteran is defined as an individual who has served in a branch of the U.S.
military. A crucial component in working with veterans is being familiar with military
terminology, norms and belief systems of veterans, and the camaraderie that exists among
this population (Meyer & Wynn, 2018). The identity of being a veteran is quite important
and needs to be respected and honored by clinicians providing services (Meyer & Wynn,
2018).
Veteran Characteristics
There are numerous characteristics that clinicians should be aware of when
working with veterans. During their military life, veterans may have experienced frequent
separations from their families. They may continue to abide by a philosophy that the
“mission must come first,” may feel a level of detachment from nonmilitary life, and may
maintain an authoritarian structure such as that typically experienced within all branches
of the military (Meyer & Wynn, 2018).
Subcultures are present within the military that separate individuals into groups
such as officers versus enlisted, which create some social distance within the military
itself (Hall, 2011). Knowledge of a veteran’s rank can be beneficial upon meeting with
him or her initially, as this can provide information about potential viewpoints and
attitudes, as it is common for officers’ viewpoints to differ from those of lower ranking
personnel (Hall, 2011). An additional consideration involves veterans often seeing
clinicians as authority figures, which can render the establishment of rapport more
challenging (Hall, 2011).
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Another subculture within the military includes combat veterans (Meyer & Wynn,
2018) who may have served in war locations, such as Korea, Vietnam, Iraq, or
Afghanistan. There are also conflicts that are not officially considered wars, but in which
veterans still served in a combat environment. Communication among these individuals
can be unique, particularly with trading “war stories” or sharing their experiences during
service time. A shared trauma may also exist and is identified among those who
experience PTSD symptoms. This can be a challenge for civilians to understand due to
the shared experience of trauma and the bond it creates.
An additional cultural consideration to understand about veterans revolves around
the “importance of the mission” (Carroll et al., 2016). Early in basic training, enlisted
personnel are taught to see themselves as part of a team rather than as individuals; this
principle is then reinforced throughout their military career. The idea of only trusting
each other and training diligently for potential missions is a core component of the
military (Hall, 2011). The unit and mission always come first, with “weakness” never
being an option (Hall, 2011). It is important to note that there is truth to this philosophy,
in that during missions, personnel can only trust each other (Hall, 2011). When they leave
the military and become veterans, this mindset has become engrained in them.
The warrior mentality establishes stoicism and the need for (mission) secrecy, as
these are necessary aspects of combat (Meyer & Wynn, 2018). This philosophy, along
with the stigma associated with mental health issues and a fear of being perceived as
“weak,” can be a barrier for veterans seeking treatment (Teeters, Lancaster, Brown, &

21
Back, 2017). Gaining the trust of a veteran, due to these factors, can take patience, time,
and empathy (Meyer & Wynn, 2018).
Co-Occurring Mental Health and Substance Abuse Disorders Among Veterans
The rate of co-occurring mental health disorders and substance abuse among the
veteran population continues to be concerning, although there are some indications that
rates of alcohol-use disorders are declining (Lan et al., 2016). A meta-analysis reviewing
37 studies between 1995 and 2013 in the VA system reported that the decrease in
reported alcohol-use disorders may be due to increased awareness of alcohol abuse in the
veteran population (Lan et al., 2016). However, the rates of both drug and alcohol abuse
remain problematic overall. The authors (Lan et al., 2016) posited that these issues may
be at least partly attributable to concurrent mental health symptoms that veterans are
attempting to self-medicate.
A study conducted to determine rates of substance use disorders among veterans
presenting for VA services the first time identified that 11% met criteria for a substance
use disorder diagnosis (Teeters et al., 2017). Furthermore, the investigators noted a higher
rate among veterans aged 18-25 compared to their civilian counterparts. Overall, within
the groups of veterans (Teeters et al., 2017), those who were designated as Operation
Enduring Freedom (OEF) and Operation Iraqi Freedom (OIF) had higher rates of both
substance use disorders (SUD) and COD. The most prevalent comorbid disorders with
substance abuse include major depressive disorder (Yoon, Petrakis, & Rosenheck, 2015;
Zisook et al., 2016) and PTSD (Coker, Stefanovics, & Rosenheck, 2016). However,
other psychiatric disorders that are noted to be problematic among veterans with
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substance abuse include schizophrenia, obsessive-compulsive disorder, social phobia,
panic disorder, and generalized anxiety disorder (Bonn-Miller, Harris, & Trafton, 2012).
An investigation reviewing all VA Healthcare System records was completed to
determine changes in the rates of cannabis use disorders from 2002 to 2009 (Bonn-Miller
et al., 2012). The researchers identified an increase of 59.12% for those with diagnoses
related to cannabis use disorder from 2002-2009. Additionally, they discovered
significant rates of other substance abuse issues among veterans with mental health
issues, including increases in use of alcohol, amphetamines, cocaine, and opioids (BonnMiller et al., 2012).
Barriers and Other Factors Complicating Treatment
There are numerous factors to consider in working with veterans who have cooccurring disorders, including the high rate of suicide, TBI, MST, chronic pain issues,
and barriers to treatment, such as stigma, probation and parole status, and homelessness.
In the MH RRTP, these are all concerns that may be addressed during the treatment
episode of care.
Veterans and Suicide Rates
The increase in veteran suicides over the last 10 years has become an important
focus of attention in many studies (Bossarte, Claassen & Knox, 2010; Castro & Kintzle,
2014). It is estimated that the current number of suicides among veterans is 22 per day, or
as many as 8,000 per year (Castro & Kintzle, 2014). There are often substance abuse and
mental health issues present among veterans who are at highest risk for suicide, including
PTSD, depression, anxiety, schizophrenia, and bipolar disorder (McCarthy et al., 2009).
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A longitudinal study (Ilgen et al., 2010) examined National Death Index data and
Veterans Health Administration patient records to investigate the relationship between
veteran suicides and mental health diagnoses. Results of the study indicated a strong
correlation between a psychiatric disorder diagnosis and increased suicide risk (Ilgen et
al., 2010). Additionally, among male veterans, bipolar disorder was most strongly
correlated with suicide, while substance abuse disorders were present more often than
other psychiatric disorders for female veterans (Ilgen et al., 2010). Additional findings in
an investigation of suicide rates among veterans (Hoffmire, Kemp, & Bossarte, 2015) led
to the assertion that suicide rates declined for veterans who used VHA services from
2000 to 2010 (Hoffmire, Kemp, & Bossarte, 2015). This may suggest that veterans who
do not use VHA services are at higher risk of suicide. This would provide additional
evidence of the importance of having effective interventions in the VHA system as well
as outreach to veterans who are not currently using VHA services.
Traumatic Brain Injury
TBI is often seen in post-9/11 veterans (Gros, Korte, Horner, & Brady, 2016),
who were formerly referred to as OIF and OEF veterans. In this group of combat
veterans, individuals were often involved in multiple tours and experienced numerous
blasts resulting from improvised explosive devices (IEDs). Combined with substance
abuse and mental health concerns, the presence of a TBI can result in a more complex
treatment protocol. A study conducted by Gros et al. (2016) indicated a significant
relationship among TBIs, PTSD, and substance abuse, particularly with alcohol. A
review of VA records (Gros et al., 2016) between 2007 and 2012 revealed that of 66,089
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post-9/11 veterans who screened positive for TBI, 72% reported moderate to severe
cognitive impairments. Of those veterans, there was a significant number who also met
criteria for PTSD and depression.
Chronic Pain
Veterans, particularly those who have been in combat, often have co-occurring
pain issues, and use of substances may be an attempt to self-medicate for the pain
experienced. This is an additional consideration in MH RRTP, where veterans are
encouraged to participate in healthy pain management skills and methods. Studies have
demonstrated a significant concern for veterans with concurrent pain issues. For example,
Phillips et al. (2016) discussed pain and psychiatric comorbidities among post-9/11
veterans by conducting a multivariate analysis of covariance (MANCOVA) on
differences among self-report measures of symptoms. They reported that no significant
differences were noted for age, but there were higher rates across the 359 participants for
moderate to severe pain, mood disorder, and anxiety disorders (non-PTSD) among those
who met criteria for comorbidities (Phillips et al., 2016).
Military Sexual Trauma
The question of how MST relates to higher rates of substance abuse and cooccurring mental health issues was examined via a study reviewing records of 499,822
veterans who had served in Iraq or Afghanistan and completed the MST screening
(Gilmore et al., 2016). The authors reported findings of significance for veterans with
positive MST screens having higher rates of PTSD, substance use disorders, and
depressive disorders (Gilmore et al., 2016).
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Veterans and Homelessness
Making the issue of substance abuse and mental health issues among veterans
even more complex is the high rate of homelessness that exists in this population (Yoon
et al., 2015). An investigation of demographics with 300,000 veterans was conducted by
using a VA system chart review. It was determined that a high rate of homelessness is
often comorbid with substance abuse and mental health disorders (Yoon et al., 2015).
Exact percentages of homelessness among veterans are difficult to attain due to the
“point-in-time” counts that are conducted, which only identify individuals who can be
located and counted (Tsai, Link, Rosenheck, & Pietrzak, 2016). However, it was noted in
one study that 8.5% of veterans had reported being homeless at some point, while only
17.2% of those reporting using VA services to address this issue (Tsai et al., 2016).
Additionally, the 2016 annual assessment of homelessness to Congress reported that there
were nearly 39,471 homeless veterans (Henry, Watt, Rosenthal, & Shivji, 2016);
although this figure had decreased by 46% since 2009, homelessness has remained a
problem that may exacerbate co-occurring disorders.
Justice-Involved Veterans
Veterans who are involved with the criminal justice system often lack awareness
about treatment options or are unable to get appropriate care due to their legal issues
(Glynn et al., 2016). Veterans may also be at greater risk for legal problems, from driving
violations to more extreme changes. For example, when individuals have been in a
deployment situation with accompanying trauma, they learn to drive in a manner to avoid
encountering an IED. When they return to the United States, this driving pattern has
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become engrained, and veterans may receive moving violations on a more frequent basis
than civilians (Crane, Schlauch, & Easton, 2015). Additionally, returning military
personnel may experience difficulties with reintegration and continue to have a combat
mindset, leading to other legal issues, including violent offenses (Crane et al., 2015).
Additional Barriers
There are numerous other barriers to treatment that have been identified among
researchers. In some VA facilities, there are not enough mental health staff available,
while other veterans may have competing basic needs or be ineligible for services (Glynn
et al., 2016). Cost and lack of insurance have been problematic for individuals seeking
treatment, particularly among the civilian sector (Rowan, McAlpine, & Blewett, 2013).
Priester et al. (2016) asserted that when co-occurring disorders are left untreated,
individuals face increased odds for medical illness, suicide, shorter lifespan, risk of
homelessness and incarceration. The investigators completed a review of 36 articles to
identify barriers to treatment. These included excessive wait lists, a lack of culturally
competent and specialized services, and a lack of stable housing (Priester et al., 2016).
The researchers also identified potential solutions including reducing “red tape,” offering
evening and weekend services, providing transportation options, and improving training
for professionals (Priester et al., 2016). Data studied from 10,384 veterans who scored 8
or higher on the Alcohol Use Disorders Identification Test (AUDIT-C) indicated that
only 3.9% were receiving treatment for substance abuse (Glass et al., 2010).
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Working Through the Barriers
The concerns and barriers veterans may face during treatment are addressed
concurrently, to the greatest extent possible, in the MH RRTP. There are various
resources to assist with legal obligations, including assistance from a VA Justice
Outreach Coordinator, steps that can be taken to assist with housing, and suicide risk
assessments and interventions including formulation of safety plans. Veterans are
provided information and interventions to assist with chronic pain in a healthier manner,
including use of physical therapy and mindfulness techniques. If they are deemed to be at
risk of having experienced a TBI, further assessments are completed. This approach is a
major benefit to incorporating an integrated treatment model, as it not only addresses the
co-occurring substance and mental health disorders, but also provides a type of
wraparound service to make life stressors more manageable.
Mental Health Residential Rehabilitation Treatment Program
The history of the Saint Cloud MH RRTP is important to consider due to the
significant changes made to the program over the past decade. Prior to 2007, the MH
RRTP was primarily a substance use disorder program. Residential programs in the entire
VA system began after the civil war, but at that time were called Veterans Homes and
were run by veterans. In later years, they gradually began to change into psychosocial
rehabilitation programs. There are currently 244 MH RRTP facilities in the VA system
throughout the United States.
The Saint Cloud MH RRTP began in the 1950s and was primarily focused on
substance abuse interventions, such as 12 step programming. In the past 10 years, the MH
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RRTP has transformed into a co-occurring disorder treatment program and has also
placed increased focus on safety. As identified by Jeremy Maurstad, the MH RRTP
Domiciliary Chief at the time of this study, this includes 24/7 licensed staff, closed circuit
television, medication management, keyless entry and a mental health design to
maximize privacy, and safety for the veterans (J. Maurstad, personal communication,
January 17, 2018). The Saint Cloud MH RRTP is unique in its approach with utilizing
outcome measures, evidence-based treatment, and a constant continuous improvement
loop by implementing objective measurements and pre and post-outcomes. There are
several other MH RRTPs attempting to replicate the program being studied and one other
facility has made a full transition in replicating the program successfully (J. Maurstad,
personal communication, January 17, 2018).
The focus of this study, the Saint Cloud VA MH RRTP, is a 148-bed residential
facility in the Veterans Affairs Healthcare System that specializes in treating veterans
with substance abuse, mental health concerns and a combination of both issues, referred
to as co-occurring disorders (CODs). The program uses several types of interventions,
primarily in a group format, with a focus on a person-centered approach as noted in the
integrated treatment model. Veterans, in consultation with their assigned primary case
manager, determine their length of stay in the program, typically 27-60 days depending
on the veterans’ preference, problems and symptoms, housing status, and obligations
outside of treatment. They are instrumental in identifying their treatment plan goals,
objectives, and interventions.
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Group Format
While two core groups, stages of change/motivational interviewing and
enhancement (SCMI) and cognitive behavioral therapy (CBT), are mandatory, there are
many other potential groups that veterans may choose from during their treatment
episode of care. These include a focus on relapse prevention, mindfulness, acceptance
and commitment therapy (ACT), PTSD symptom management, cognitive-processing
therapy for PTSD, stress management, inner conflict, coping with guilt and shame,
nutrition and cooking, chronic pain, sleep issues, and recreational therapy. Veterans also
have access to peer support specialists via individual and group formats and attend a
choice of SMART Recovery, Alcoholics Anonymous (AA), Narcotics Anonymous (NA),
or Emotions Anonymous (EA). Veterans are also encouraged to utilize a fitness center,
bowling alley, and therapeutic pool onsite, pending medical provider approval. They have
access to yoga and other holistic approaches, as well as individual therapy upon request,
in addition to their therapy groups. Veterans and their primary case manager discuss the
various interventions available to establish a treatment plan based upon the strengths,
needs, abilities, and preferences (referred to as SNAP) of the veteran. This is what truly
makes the MH RRTP unique; veterans are offered a “buffet” of choices within the
treatment program to truly fit their individual concerns and goals.
Multidisciplinary Approach
The elective groups are held for one to two weeks and are facilitated by various
disciplines, including social workers, psychologists, peer support specialists, registered
nurses, and recreational therapists. Additionally, veterans are seen by psychiatry as
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needed, a medical provider, and pharmacist at admission and discharge from the
program. Medication management is provided on site and there is a 24/7 staff presence
that includes Licensed Practical Nursing staff and Social Service Assistants.
Quadrant System
The veterans in MH RRTP are assigned to teams based on the quadrant model
(McDonell et al., 2012) as follows: Team 1 consists of veterans with high mental health
needs and low or no substance abuse; Teams 2 and 3 consist of veterans with low to
moderate mental health and moderate substance use disorders; Team 4 is for veterans
with a high level of need related to both substance and mental health disorders; and Team
5 is for high substance abuse and low/no mental health issues. It is noted that there is
some variation to the original quadrant model in that Quadrant 1 is typically for
individuals with lower substance and mental health needs and are more often seen in an
outpatient setting. Also, Team 5 is an addition to serve veterans who may have lower
mental health issues, but a high level of substance abuse. In using this model, the veterans
are on teams and participate in core groups with other veterans who have similar needs
and problems.
The process of admission into MH RRTP. A veteran first begins the process of
admission into MH RRTP by contacting a screening line that is answered by a Social
Services Assistant (SSA) or Licensed Practical Nurse (LPN) who takes basic information
from the veteran and assesses for any emergent needs. The veteran is given a time/date
that a screener, either a master’s level social worker (MSW) or registered nurse (RN) will
be in contact to complete the full admission screening. Once this has been completed and
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the veteran has been accepted to the program, an agreed upon date for admission is
established. The veteran is admitted on that date, meets with a psychologist or social
worker for an assessment and a medical provider for a history and physical exam. The
veteran is assigned to a team based on the quadrant that is most appropriate as determined
during the biopsychosocial assessment, while also considering the individual’s needs and
goals. The veteran then meets with a primary case manager, which may be an addiction
therapist, MSW, or RN. At the treatment planning session, the veteran and primary case
manager identify a discharge date, goals, and the core and elective groups that will be
attended. The case manager is also responsible for conducting a mid-point treatment
review and discharge planning throughout treatment. This individual also often provides
facilitation of various groups in the program, including at least one of the core groups that
the veteran attends (either the SCMI or CBT group).
Theories and Interventions
The integrated treatment model is the theoretical framework for this study and
influences the interventions used in MH RRTP. This model includes several concurrent
treatments for mental health and substance abuse concerns, medication management,
motivational and cognitive-behavioral interventions, and multiple formats, including
group, family, individual therapies, and a focus on recovery as opposed to the medical
model. As part of this model, there is a great deal of focus on CBT and SCMI, the core
groups in MH RRTP.
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Integrated Treatment Model
The integrated treatment model is a recovery-oriented approach that has been
identified as a best practice for COD (co-occurring disorders) treatment (Priester et al.,
2016). Previous research has sometimes referred to this model as integrated dual disorder
treatment (IDDT). The concept of treatment for both substance abuse and mental health
issues concurrently became more widely accepted since the late 1980s (Minkoff, 1989)
when studies indicated that treating these issues separately was not providing significant
outcomes. While this model is not new, the practice of utilizing it among the veteran
population within the VA system, specifically within residential settings, is more recent.
The integrated treatment model is multi-faceted and includes use of CBT,
motivational enhancement via the stages of change, peer support, and a focus on selfdetermination and recovery. The qualities that make up an effective approach were
described in a meta-analysis that was conducted to include 24 studies with 100 agencies
(Torrey, Tepper, & Greenwold, 2011). The researchers used the meta-analysis primarily
to explore the potential difficulty of implementation of an integrated treatment model and
to identify the qualities that make up a well-rounded and beneficial treatment program for
co-occurring disorders (Torrey et al., 2011). These included the importance of leadership,
lower turnover rates in staff, consultant-trainer resources, available clinical supervision,
and adequate finances for the program (Torrey et al., 2011).
There are several additional studies that identify this model as an effective
approach to treatment, but only a few that focus on residential treatment for veterans. In
one investigation, a meta-analysis of twelve studies was conducted to determine the
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effectiveness of an integrated treatment model, which utilized a combination of CBT and
motivational interviewing. They compared use of CBT and MI to a “treatment as usual”
control group with individuals having both substance use disorders and depression (Riper
et al., 2014). In this sample of 1,721 patients, it was noted that the combination of CBT
and MI led to a small, but clinically significant effect in outcomes when compared with
the control group (Riper et al., 2014).
Jones et al. (2011) also offered insights into using a combination of CBT and MI
as a treatment for individuals who have both substance abuse and bipolar disorder. While
this study was not based in a residential program, it did offer informative results of using
a combination of CBT and MI as treatment for individuals who have both substance
abuse and bipolar disorder (Jones et al., 2011). The researchers implemented a case study
approach with five individuals diagnosed with co-occurring bipolar disorder and
substance abuse. The authors asserted that this was the first study investigating the impact
of CBT and MI for these comorbid disorders (Jones et al., 2011). The results indicated
mixed responses, including three individuals who identified their primary substance as
marijuana, and reported a reduction in their use following the intervention. Of the two
individuals who identified alcohol as their primary substance, one decreased use
significantly, while the other decreased only slightly (Jones et al., 2011). Although the
results were mixed, and the participants were “complex” as described by the researchers
(Jones et al., 2011), this study reported evidence of this therapy leading to positive
results. A limitation to this study is the small number of participants, and it is possible
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that more intensive delivery methods that are offered in MH RRTP may impact
symptoms more substantially.
Another investigation was completed via a multi-center study of dual diagnosis
programs at three sites with a similar treatment program curriculum (Schoenthaler et al.,
2017) that used the integrated treatment model. Participants with co-occurring disorders
were administered the Addiction Severity Index at admission to the program and then at
one, six, and 12 months after discharge to evaluate sobriety maintenance. Approximately
one-third of the participants reported no intoxication at 12 months after discharging from
the program, which is a significant rate when considering the typically high rate of
relapse for substance use disorders. Of the participants in this study who did relapse,
many still reported a decrease overall in using or drinking behavior (Schoenthaler et al.,
2017).
A smaller study investigated the integrated treatment model for CODs within an
outpatient facility in Ontario (Milosevic, Chudzik, Boyd, & McCabe, 2017). The final
sample of 29 participants completed readiness for change measures, a quality of life
questionnaire, and other self-report measures, which indicated a reduction in drinking.
However, the depression and anxiety self-report measurements varied indicating mixed
results. The small sample size did pose a limitation to this study (Milosevic et al., 2017).
It has been stated that while residential treatment can impact positive outcomes,
the effects are not generalizable outside of this environment (McKee, Harris, & Cormier,
2013). This notion has impacted residential programs to focus on changes for clients to
practice their skills in more “real world situations” such as taking weekend or day passes
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outside of the program. Additionally, changes to some residential programs to
incorporate integrated treatment has been helpful in extending the skills in post-treatment
environments. A study that focused on these changes was conducted in a residential
program in Canada with initially 155 individuals participating in the study, and 86
completing the program (McKee et al., 2013). The program was transformed from a
traditional residential program to an integrated treatment model and the authors
investigated the impact of these program changes. Fidelity to the model was completed
via consultations and scores on the Integrated Treatment Fidelity Scale to ensure that this
remained a priority (McKee et al., 2013). Several measurements were used for self-report
of symptoms including the Beck Depression Inventory-II, the Beck Anxiety Inventory,
Brief Psychiatric Rating Scale, and Personality Diagnostic Questionnaire. The selfreported scores were compared at start, midpoint, and completion of the treatment to
determine potential significant changes (McKee et al., 2013). They also compared the
same measurements completed by a waitlist control group. The study demonstrated that
treatment participation was associated with clinically significant improvements in
symptom reduction, improvements in life satisfaction, and increased ability to maintain
sobriety and life skills (McKee et al., 2013). It also illustrated the importance of strong
leadership and low staff turnover in maintaining positive outcomes of the treatment
interventions and the Integrated treatment model.
A study using a 28-day Minnesota model was described by the authors (Bergman,
Greene, Slaymaker, Hoeppner, & Kelly, 2014) as using 12-step facilitation, CBT, and
Motivational Enhancement interventions, which is similar to the protocol of the treatment
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at the MH RRTP using the integrated treatment model. This investigation included 300
participants ranging from ages 18-24 who were recruits from Hazelden Center for Youth
and Families. The researchers noted potential outcomes that were gathered at discharge,
three months, six months, and 12 months post-discharge (Bergman et al., 2014) and
compared a substance use disorder (no co-occurring mental health diagnoses) group with
co-occurring disorders to determine differences in outcomes. The group with cooccurring disorders demonstrated greater symptom decreases as compared with the
substance use-only group of participants, although positive overall main effects were
present for both groups (Bergman et al., 2014).
Lastly, in a study completed by Toneatto and Calderwood (2015), participants
were randomly assigned to receive either six individual sessions of alcohol-only
treatment (ALC) or to an enhanced treatment consisting of six alcohol-only sessions,
identical to the ALC group, followed by four sessions of anxiety management
(ALCANX). It was found that including four additional sessions focusing exclusively on
anxiety management made no significant difference with both treatments performing
equally well. This demonstrated the impact of CBT as an effective therapy with or
without the use of other interventions (Toneatto & Calderwood, 2015). However, the MH
RRTP study emphasized use of concurrent SCMI/CBT.
Transtheoretical Theory
A major component to MH RRTP and the integrated treatment model is the
transtheoretical theory, also referred to as the “stages of change.” First presented by
Prochaska and DiClemente (1982), the primary focus of this theory is to understand and
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meet individuals where they are currently, rather than try to “push” them into being
motivated for change. Prochaska and DiClemente were interested in examining what
factors appear to motivate individuals for making sustained life changes and have studied
this theory extensively over the past several decades, with modifications made over the
years (DiClemente, Corno, Graydon, Wiprovnick, & Knoblach, 2017; DiClemente &
Hughes, 1990; Prochaska, DiClemente, & Norcross, 1992; Velasquez, Crouch, Stephens,
& DiClemente, 2016).
During that time, this theory has been identified as a major contributor to
determining individuals’ continued motivation for recovery. The stages of change
include: pre-contemplation (the person is in denial that a problem exists), contemplation
(aware that a problem exists and entertaining the possibility of change), preparation
(preparing to change), action, maintenance and relapse, which then can begin a new cycle
(Walsh, 2010). The primary therapies that have been associated with moving people from
pre-contemplation through the other stages to action/maintenance are motivational
interviewing and enhancement.
Motivational Interviewing and Enhancement Interventions
Motivation is a well-known predictor of abstinence and continued recoveryoriented attitudes following treatment episodes. There are various techniques involved in
motivational interviewing (MI) and motivational enhancement therapy (MET), using the
stages of change model, that include circular questioning, reflective listening, and
education (Velasquez, Crouch, Stephens, & DiClemente, 2016). In the core MH RRTP
group, SCMI, the curriculum and discussions focus on assignments that increase
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motivational enhancement, such as improving communication, identifying pros and cons
of substance abuse versus sobriety, discussing values, improving problem solving, and
setting goals (Velasquez et al., 2016). The notion of neutrality is utilized to encourage
changes in motivational levels with circular questioning being a crucial aspect of this
technique with use of collaboration rather than confrontation (Walsh, 2010). This method
is often referred to as motivational interviewing, which Van Wormer (2007) described as
a “non-confrontational model based on the fundamental truth from social psychology that
decisions to move toward change are more powerful if they come from within” (p. 22).
Interventions include providing empathy, reinforcing statements made regarding
the desire to change, and asking questions that can elicit self-motivational statements
(Walsh, 2010). As a preamble to circular questioning, reflective listening is crucial to
develop changes in motivation levels. It has been described as the foundation of
motivational interviewing (Rosengren, 2009) and includes expressing empathy and
interest, while simultaneously challenging an individual gently by making statements
rather than questioning. For example, instead of asking “so do you feel like you’re not
being heard?” one would make a statement “so you feel like you’re not being heard”
(Rosengren, 2009). Providing empathy and conveying understanding of how the client
might be feeling allows the individual to confirm or deny the clinician’s perceptions
openly (Rosengren, 2009).
MI has been used for a variety of areas and age groups to promote the change
process and utilize a client’s strengths. The studies that demonstrate the usefulness of this
strategy are numerous. One such study includes an investigation by Brown et al. (2015)
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with adolescents, ages 13-17, who were diagnosed with both mental health and substance
use co-occurring disorders. The participants were recruited during an inpatient
hospitalization treatment episode and were randomly assigned to one of two groups,
which included the typical treatment provided and another that added a MI intervention
of two, 45-minute sessions (Brown et al., 2015). Outcomes were measured at start of
treatment, completion of treatment, and again at one, six, and 12-months post discharge.
The authors (Brown et al., 2015) noted that general goals of the MI sessions
focused on increasing understanding of substance abuse consequences and gaining
knowledge about the behaviors impacting those consequences. Additional goals included
increasing awareness of readiness for changes, pros and cons of substance use, and
identifying goals and a change plan (Brown et al., 2015). The results of this study showed
mixed results. While the results were significant for the MI group as compared to the
control group with such areas as a decrease in use of substances, as well as defiant and
rule-breaking behaviors, the results appeared to only sustain for the first six months after
discharge (Brown et al., 2015). This may illustrate the point of identifying methods to
continue utilizing the interventions more long-term to maintain motivational levels.
An extensive meta-analysis of studies completed between 2007 to 2017 was
conducted by DiClemente, Corno, Graydon, Wiprovnick, and Knoblach (2017). The
researchers reviewed 144 articles, which included 34 previous reviews, to determine
efficacy of motivational interviewing and enhancement therapies on addictive disorders
and behaviors. They concluded that very strong evidence exists for efficacy of
motivational interventions with alcohol, tobacco, and marijuana addictions, as well as
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moderate support for gambling (DiClemente et al., 2017). While there were fewer studies
available regarding use of motivational enhancement therapy (MET) for other drugs, such
as cocaine, opioids, or methamphetamine, the majority of those that are available have
indicated a positive outcome for those utilizing MI/MET strategies (DiClemente et al.,
2017). Additionally, the review included studies with individuals diagnosed with severe
mental illness and indicated that the results demonstrate inconsistent findings. This leads
to the conclusion that further studies are necessary to determine the impact of MI/MET
on both mental health and substance use disorders besides marijuana and alcohol
(DiClemente et al., 2017).
Studies are also being implemented to determine the effectiveness of brief
MI/MET interventions that include just one or two sessions, which have had mixed
results indicating that traditional longer-term MI/MET interventions may remain more
appropriate in treatment. McDevitt-Murphy, Murphy, Williams, Monahan, and BrackenMinor (2014) described an intervention in their study conducted with Iraq and
Afghanistan combat veterans who received services in a VA primary care clinic. Their
intervention, termed Project Strive (Successful Transition and Readjustment for
Iraq/Afghanistan Veterans) was provided to veterans who scored at least an eight on the
Alcohol Use Disorders Identification Test (AUDIT). Participating veterans completed a
PTSD measurement in addition to the BDI-II and several other questionnaires (McDevittMurphy et al., 2014). They were then randomly assigned to one of two intervention
groups, a control group of personalized drinking feedback or the intervention group of
personalized drinking feedback and MI. The intervention group only received one
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individual MI session, which usually was about 60 minutes total (McDevitt-Murphy et
al., 2014). While this was a pilot study, with results similar in both conditions, it does
demonstrate promising potential for brief interventions (McDevitt-Murphy et al., 2014),
which have become more of a priority in the co-occurring disorders treatment field.
While the McDevitt-Murphy et al. (2014) study did not indicate a significant
difference between the non-MI group versus the MI treatment group, another study
reported significant results (Walker et al., 2017) with similar intervention strategies. The
“Warrior Check-Up” study included 242 active-duty army personnel with alcohol use
disorder as participants who were randomly assigned to either one session of MI with
feedback or one session of education (Walker et al., 2017). All contact was completed
over the telephone, which was a unique aspect to this study, in addition to both
interventions including only one session (Walker et al., 2017). This particular model was
designed specifically for army personnel to address the service-need gap for those who
do not wish to participate in traditional types of treatment. The brief intervention (Walker
et al., 2017) allows individuals to participate more anonymously and avoid major barriers
that are often cited among this population, such as the high level of stigma and worries
about confidentiality as it is “off the record.” While there were noted limitations to this
study, including the possibility of changes being due to monetary incentives for
participation, it was still noteworthy that participants in the MI group significantly
reduced drinking compared to the other group, from 32 drinks per week to 14 drinks per
week at the six-month follow up (Walker et al., 2017). Motivational interviewing and
enhancement is a key aspect of treatment in MH RRTP, as the two core groups in the

42
program, SCMI and CBT, focus on enhancing motivation for maintaining recovery and
challenging distorted self-talk that lead to distressing emotions and unhealthy behaviors.
Cognitive and Behavior Theories and Interventions
Walsh (2010) reported that cognitive theory is focused on the thought process and
is instrumental in how individuals evaluate various experiences, which then impact
judgments about behavior. Behavior theory is focused on principles of learning, which
often stems from the thought process. The combination of these theories has resulted in
an intervention of CBT, the other primary therapy used in MH RRTP.
The therapy techniques identify the relationship between thoughts, feelings and
behaviors with the emphasis on changing one’s thoughts (Beck, 2011). It asserts that an
activating event triggers or influences an individual’s perceptions or beliefs, which
influences the consequent emotions and behaviors (Beck, 2011). Interventions in MH
RRTP include education about the relationship among thoughts, feelings and behaviors
and homework assignments that challenge limited thinking patterns, conducted in the
group setting. The process of recognizing and challenging these thoughts and core beliefs
is referred to as cognitive restructuring (Walsh, 2010) by using thought journals and
worksheets. Additionally, behavioral interventions are introduced during the group
process, such as learning more effective communication methods, role playing, relaxation
strategies, and confronting anxiety-provoking situations. Veterans with substance abuse
issues are encouraged to challenge themselves by engaging in sober leisure activities.
CBT has been used as a therapeutic intervention for several decades. Within the
integrated treatment model, CBT is an essential component to assisting individuals with
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identifying problematic thinking patterns. There are numerous studies that demonstrate
the usefulness of CBT for a variety of diagnoses and issues, including depression,
anxiety, substance abuse, and PTSD. For example, Espejo et al. (2016) completed a study
with veterans diagnosed with anxiety disorders. The veterans completed 12 sessions of
group outpatient CBT (once per week for 120 minutes per session) at the San Diego VA.
The study demonstrated positive results indicating that the treatment was particularly
helpful for general distress, depressive symptoms, and anxious arousal (Espejo et al.,
2016).
Another study (Brown et al., 2016) demonstrated the usefulness of CBT for
decreasing suicidal ideation. The researchers implemented CBT for depression (CBT-D)
in several VA facilities with a total of 882 patients. Of those individuals, 463 reported
suicidal data at the three different time points that were evaluated via the BDI-II during a
course of CBT-D treatment (Brown et al., 2016). The researchers reported that for
veterans reporting suicidal ideation at baseline (mean scores were 33.4), the BDI-II mean
scores decreased to 20.8 at the final assessment, which was a statistically significant
reduction (Brown et al., 2016).
Hunter, Paddock, Zhou, Watkins, and Hepner (2013) completed a study utilizing
four residential programs funded by Behavioral Health Services in Los Angeles County.
The 299 participants were randomly placed into two groups, in which they received either
residential treatment as usual or residential treatment enhanced with group cognitive
behavioral therapy for depression (GCBT-D). The GCBT-D included 16 two-hour group
sessions and used four modules that addressed thoughts, activities, interactions, and
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substance use (Hunter et al., 2013). Outcomes were measured via self-report for
depression symptoms with the BDI-II, the 12-item Short Form General Health Survey,
and the Mental Health Composite Score (Hunter et al., 2013). The authors noted that the
baseline measurements did not detect any significant differences, but at the six-month
follow up significant differences were found. They also reported that the response rate for
both groups was similar. The overall results indicated that GCBT-D was associated with
improved mental health and substance use outcomes (Hunter et al., 2013). Notably, there
were some differences among ethnicities, with Caucasians reporting more of a decrease
in symptoms than other ethnicities, which the authors posited as providing evidence for
the importance of increasing the availability of individualized treatment options (Hunter
et al., 2013).
The use of CBT for anxiety and depression is well-known and accepted as an
effective intervention technique among many clinicians and researchers. However, it has
also been demonstrated as having a positive impact on other issues, such as insomnia,
especially with veterans who have PTSD (Margolies, Rybarczyk, Vrana, Leszczyszyn, &
Lynch, 2013) and is now being delivered in other formats, such as through digital
methods (Luik, Kyle, & Espie, 2017). As with motivational enhancement strategies, CBT
has become an integral part of MH RRTP treatment interventions within the integrated
treatment model.
Residential Treatment Outcomes
Flynn and Brown (2008) demonstrated the importance of increasing the
availability of interventions for co-occurring disorders, but also acknowledged the need
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for further studies to make more conclusive arguments regarding program and
intervention effectiveness. The results from residential treatment of co-occurring
disorders within the general population have been varied. For example, the study
completed by McKee, Harris, and Cormier (2013) included 86 participants diagnosed
with co-occurring disorders in a small residential facility. They reported positive gains in
coping skills and overall symptom management of the individuals who participated in the
study.
A meta-analysis of residential programs demonstrated an overall moderate level
of evidence for effectiveness of residential treatment (Reif et al., 2014), but noted some
studies in the meta-analysis indicated no significant differences in outcomes for
individuals in residential programming compared to other types of treatment, such as
outpatient services. The authors of this study (Reif et al., 2014) included a concrete
differentiation among low, medium, and high levels of intensity within types of
residential programs. They defined the overall service goal, which included providing
stable living environments while learning coping skills for recovery.
The authors aimed to determine effectiveness of residential treatment for
substance abuse issues and completed a thorough search for articles from 1995 to 2012
(Reif et al., 2014). Several exclusion criteria were implemented, including studies that did
not provide comparison groups, those that focused on adolescents, or those within a
criminal justice system due to the likelihood of motivations that are different from other
programs (i.e. being “forced” into treatment versus voluntary). The researchers then
identified, reviewed, and compared eight reviews and 21 studies to determine a moderate
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level of success among residential treatment programs (Reif et al., 2014). The authors
recommended further research that identifies which individuals respond best to
residential treatment, as population differences exist. They also recommended further
studies specifically examining differences in outcomes based on length of stay length of
stay in residential programs.
Giorgi, Ottonello, Vittadini, and Bertolotti (2015) completed a study of 560
patients who completed a 28-day residential program. All participants were diagnosed
with an alcohol use disorder and just over half reported addictions to additional
substances. Among the participants, 41% had a personality disorder diagnosis, 28% had
mood disorders, 12% had an anxiety disorder, and a small percentage (4%) had psychosis
(Giorgi et al., 2015). The treatment consisted of several daily group sessions focusing on
motivational enhancement, education, and relapse prevention. They also were involved in
various leisure activities and therapies that included relaxation and art therapy (Giorgi et
al., 2015). A self-report measure, the Cognitive Behavioral Assessment Outcome
Evaluation, was used to identify areas regarding impulsivity, anxiety, well-being,
depression, psychological distress, and perception of change. The researchers (Giorgi et
al., 2015) reported that much like previous literature, positive changes in symptom
reduction and increases in well-being were apparent. They also indicated that the younger
participants initially had higher levels of stress and anxiety, but a higher probability of
positive change upon treatment completion (Giorgi et al., 2015).
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Veteran-Specific Residential Treatment
While residential treatment in the civilian population has been the subject of
numerous studies, there are fewer that specifically address the veteran population,
particularly for co-occurring disorders, as many tend to focus on various forms of
substance abuse rather than concurrent mental health disorders, or they focus on PTSD
and co-occurring substance abuse. As an example, a study at the Salem Veterans Affairs
Medical Center consisted of 137 veterans who participated in a 28-day residential
program (Vest et al., 2014). While the study emphasized tobacco addiction, the
investigators also identified the impact of treatment on substance use disorders at a onemonth follow up with 97 of the veterans. The treatment of the program included CBT,
education, and SCMI (Vest et al., 2014). They noted that at the one-month follow up,
90.7% (88 participants) had abstained from alcohol and 91.8% remained abstinent from
other drugs (Vest et al., 2014).
Another study investigated post-treatment relapse five years after 207 veterans
discharged from a VA residential program (Decker, Peglow, Samples, & Cunningham,
2017). The researchers included veterans who had completed successfully (regular
discharge) and those who discharged prior to their established discharge date (referred to
as an irregular discharge). The treatment program is open-enrollment and requires all
veterans to stay for 60 days, rather than establishing a length of stay length of stay based
on the veteran’s preference. In this study, it was identified that 76% relapsed during the
five-year time frame (Decker et al., 2017). However, those who did not complete the
treatment, had a higher relapse than those who did (Decker et al., 2017). This
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demonstrated the impact of completing a program successfully, as this in itself can be an
important component of recovery.
A different perspective was discussed in a study completed by Cook et al. (2013)
in which the researchers gathered information via 38 VA residential sites and interviewed
267 staff of these programs. Surveys were completed prior to the visits that including
questions about policies, treatments, and organizational structure, followed by a two-day
site visit (Cook et al., 2013). The qualitative study results indicated several important
observations and concerns that should be considered regarding VA residential programs.
These include mindfulness about changing needs in the veteran population and some
differences in symptom presentation among age groups, including post-9/11 veterans
tending to have more acute PTSD and other mental health symptoms, a lack of readiness
and time demands for treatment, and other readjustment issues such as housing (Cook et
al., 2013). There were also some concerns noted about potential disconnect among
various eras of veterans. However, other individuals noted that often the older veterans
provide a type of mentorship to the younger generation, which is beneficial for treatment
outcomes for many in residential programming (Cook et al., 2013).
The notion of peer relationships impacting residential treatment success, as
discussed by the VA staff in the Cook et al. study, was examined in an investigation
specifically identifying how these relationship dynamics effect goals and outcomes in a
VA residential program (Harrison, Timko, & Blonigen, 2017). The participants
completed a personality inventory at the beginning of treatment, which indicated that
overall veterans in treatment tended to have more interpersonal problems by one standard
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deviation (Harrison et al., 2017). They also reported a significant association for specific
personality styles having poorer outcomes, while those who had stronger connections
among their peers reported more positive experiences in treatment outcomes (Harrison et
al., 2017). Encouraging veterans in a residential program to maintain positive peer
relationships appears to be an important component to their recovery.
Length of Stay and Age Groups
While the research that focuses on differences in outcomes for length of stay is
limited, a study that did investigate this topic was completed by conducting a metaanalysis of 28 programs in the VA system with 1,307 participants (Harris, Kivlahan,
Barnett, & Finney, 2011). The lengths of stay were divided into 15-30, 31-45, 46-60, 6190, and more than 90 days. The programs with participants who stayed more than 90 days
demonstrated the least improvement in the Addiction Severity Index measure (Harris et
al., 2011). However, a significant limitation to this study is that the researchers only
analyzed substance abuse programs in the VA (Substance Abuse Residential
Rehabilitation Programs or SARRTPs), not co-occurring disorder programs. Therefore,
they did not measure or treat concurrent mental health issues (Harris et al., 2011).
Additionally, they did not describe use of the integrated treatment model in their analysis
or the specific treatment curriculum or interventions in any of the residential programs.
A study by Coker, Stefanovics, and Rosenheck (2016) was completed by
reviewing records of 12,270 veterans who had participated in intensive PTSD and cooccurring substance abuse programs throughout the VA Healthcare System from 19932011. The researchers measured outcomes from admission to four months after discharge
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that focused on continued abstinence and decreased PTSD symptoms, such as irritability,
hyperarousal, emotional numbness, flashbacks, and intrusive thoughts (Coker et al.,
2016). The researchers reviewed outcomes from different types of programs, including
short-term acute settings (less than 14 days), specialized inpatient PTSD programs (28-90
days), PTSD residential programs, and day hospital programs, which are similar to
residential programs, but veterans reside in the community (Coker et al., 2016).
The outcomes of this study demonstrated greater efficacy among the longer length
of stay programs, but the researchers noted that the improvement may be due to the
intensity of the programs rather than the length of stay. They also discovered that those
who were discharged prior to treatment completion (irregular discharge) had poorer
outcomes for abstinence, than those who completed treatment on the discharge date that
had been agreed upon during the admission process (Coker et al., 2016).
To investigate potential differences among age groups, Morse, Watson,
MacMaster, and Bride (2015) completed a study to determine variations between older
and younger individuals seeking treatment for co-occurring disorders. This was not a
study with veterans, but rather the general population in the United States and Canada.
Outcomes were not necessarily stressed in this study, but rather provided information
about the participants’ motivation for treatment and differences in symptoms and
substances abused. They noted three main findings regarding pretreatment characteristics,
types of substances abused among the different age groups, and external versus internal
motivation for sobriety (Morse et al., 2015). The authors also reported pretreatment
characteristics which differed among age groups. For example, the older adults tended to
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abuse alcohol, while younger adults had typically used cocaine, opiates, heroin,
marijuana, and amphetamines.
Regarding the results of treatment, there was little difference in readiness to
change measures, but older adults typically stayed in treatment for a significantly shorter
timeframe (Morse et al., 2015). Interestingly, the authors noted that older adults in the
study tended to have more significant psychiatric concerns but participated in fewer days
of treatment. However, the authors posited the possibility of these individuals placing a
greater perceived importance on their mental health in contrast to the younger
participants.
Veterans’ Perceptions of VA Care
Blonigen, Bui, Harris, Hepner, and Kivlahan (2014) completed a study with
veterans via phone surveys to gain information about their perceptions of care within the
Veterans Healthcare System. They acknowledged that recovery is multifaceted and
expressed concern about a gap in the literature for this population. They also recognized
that previous research has noted a relationship between better outcomes and positive
perceptions of care (Blonigen et al., 2014). The most important aspects identified in their
care included perceptions of staff empathy and support, as well as collaboration with goal
development that extends beyond symptom management. They noted the importance of
staff assistance with life goals and recovery-oriented practices, such as working on
additional goals that included family relationships, physical fitness, employment, and
education (Blonigen et al., 2014).
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Another study investigating the importance of veteran and staff collaboration with
mental health and substance abuse recovery was completed by Hepner et al. (2014). A
survey was completed via telephone interviews with a random sample of over 5,000
veterans. The individuals had received care for five main identified disorders: PTSD,
schizophrenia, bipolar I, major depression, and substance use disorders (Hepner et al.,
2014). Perceptions of care regarding timeliness, staff’s recovery orientation, psychosocial
services, and overall satisfaction were assessed during the phone interviews. Timeliness
measures were broken down into routine versus urgent care. Psychosocial services
included two main areas: perceived need for housing help and employment help.
Within the measure of staff orientation to recovery methods, there were seven
aspects: asking about patient interests, including others in treatment planning, listening
and respecting decisions, encouraging hope and high expectations, believing in the ability
to make choices, introducing veterans to role models or mentors, and assisting with goal
development and life goals (Hepner et al., 2014). The results gathered indicated that 42%
were highly satisfied with their care at the VA, 74% reported being helped by the care
received, but only 32% reported symptom improvement. The researchers indicated that
positive perceptions of care are highly important in a variety of aspects, including actual
health outcomes. This is an area that the VA has been working on improving by
identifying characteristics of person-centered and recovery-based care, such as what is
emphasized at the MH RRTP and the integrated treatment model.
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MH RRTP and Veterans’ Preferences for Treatment
The MH RRTP primarily utilizes self-report measures, including an anonymous
perceptions of care form, use of a veterans council that meets weekly with management
staff, and an anonymous card that can include complaints, concerns, or positives about
the program (J. Maurstad, personal communication, January 17, 2018). This is in addition
to the outcome-based measurement scales (the BDI-II and the BAI) that identify potential
progress in MH RRTP. The veterans’ perceptions of the program are central in making
improvements with the program and are considered part of the “continuous improvement
loop” in MH RRTP. The policies of all VA MH RRTPs include that a veteran’s strengths,
needs, abilities and preferences (SNAP) are the focus rather than illness and symptoms.
Additionally, veterans are encouraged to utilize community and other supports that assist
in success of their individual recovery and participate actively in their treatment planning,
including their therapy groups and interventions.
Summary
The length of stay differences among outcomes for veterans attending residential
treatment in the VA system and potential variations among age groups are important
components in understanding the effectiveness of MH RRTP. These two aspects of
veteran-focused treatment have been minimally researched. Additionally, the role of
veterans’ preference in establishing a length of stay length of stay in MH RRTP (up to 60
days with rare exceptions for more than that), which is discussed at admission, is an
important consideration. The information that may be discovered can be instrumental in
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making changes and impacting other residential facilities in both the VA and with the
general population.
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Chapter 3: Research Method
Introduction
The purpose of this descriptive quantitative retrospective study was to examine
whether MH RRTP impacts a decrease in depression and anxiety and improves
“protective factors” for recovery, particularly with regard to length of stay in treatment
and age. This was accomplished by using secondary data gathered from veterans who
participated in the MH RRTP during calendar years 2016 and 2017. The data were
collected during this time frame at the start and completion of treatment for staff to
examine program impact and had not been used in any previous studies. This information
may be useful for staff of the program and other VA residential facilities to consider in
program development. A descriptive quantitative retrospective study was conducted
because it allowed for an understanding of differences in Beck Depression Inventory-II
(BDI-II), Beck Anxiety Disorder (BAI), and Brief Addiction Monitor (BAM) protective
factors scores from the start to completion of treatment by using archival data.
This chapter addresses the components of this retrospective study, including the
population studied, sampling, and data procedures, followed by a description of the
instruments used in the study. Lastly, the variables, research questions, and hypotheses
are outlined, along with the research design, data analysis, and limitations of the study.
Population
The participants of this study were U. S. military veterans who served in any of
the branches of the military, received discharges that were either Honorable or General—
Under Honorable Conditions, and participated in the MH RRTP at the Saint Cloud VA
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Healthcare System. In 2017, the VA began accepting veterans for specific types of care
on an individualized basis who had received discharges related to Other Than Honorable
Conditions. There had been a very limited number of veterans in MH RRTP with this
status since the recent policy change, and it was unlikely that, if included, their results
would have impacted the data significantly. The Saint Cloud VA is part of VISN 23 and
serves areas of Minnesota, North Dakota, South Dakota, Wisconsin, and Iowa. However,
it is not unusual for veterans from other areas of the United States to seek services at this
VA facility.
Based on 2016 demographic data collected by MH RRTP staff, the veterans who
participated in the MH RRTP were primarily Caucasian (80%), followed by African
American (9%), and Native American (5%). Other ethnicities (less than 1% for each)
represented among participants included Hispanic, Pacific Islander, and Asian.
Approximately 4.5% of the veterans did not answer questions about race/ethnicity.
Participant ages varied but tended to range from 21-72 years, with occasionally veterans
in their mid to late 70s participating, and rarely, those in their 80s or 90s. Most of the
veterans participating in this MH RRTP were male, but there were typically 10 or fewer
female veterans in the program at any given time. The veterans participating in this study
had mental health and/or substance abuse disorder diagnoses. The participants had sought
treatment for these disorders on a voluntary basis, although they may have experienced
legal issues resulting in a requirement to complete some type of treatment (not
necessarily a residential program). The MH RRTP requires that veterans accepted to the
program are medically stable enough to effectively participate and able to conduct
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themselves safely in a residential environment. The program does not accept individuals
who are under commitment (admission to an inpatient program, rather than residential, is
typically more appropriate). However, in some cases, assessed on an individual basis, the
MH RRTP may accept those under a “stay of commitment” which differs from a full
commitment.
The majority of veterans in MH RRTP have a co-occurring disorder (both
substance abuse and mental health concerns), but the most common diagnoses treated in
MH RRTP include major depressive disorders, PTSD and other anxiety disorders, bipolar
disorder, and alcohol-use disorders. Additionally, a smaller percentage of veterans may
present with schizophrenia or other psychosis, personality disorders, and other substance
use disorders including those involving cannabis, opioids, methamphetamines, and
cocaine.
Sampling Procedure
The average number of veterans who participate each year in MH RRTP is
approximately 1,100-1,300 with a total of 2,631 individuals participating in 2016 and
2017. However, after implementing several exclusion criteria, the overall usable sample
size decreased to 1,136 total participants. Exclusion criteria applied to participants who
received an irregular discharge (resulting in noncompletion of initially established days in
treatment) and those who did not complete both a pre and posttest for at least one of the
measurements. These participants might have missed either the initial or discharge
outcome group when participants were asked to complete the pre and posttest BDI-II,
BAI, and BAM, in addition to other outcome measures. Another possibility was that they
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discharged from the program prior to completing these instruments due to extenuating
circumstances, such as a family emergency or behavioral concerns, prompting an
irregular discharge. An additional exclusion criterion was implemented for veterans who
attended the MH RRTP co-occurring disorders track and then transferred directly to the
PTSD track, as this increased the length of stay length of stay by 49 days and was
consecutive attendance in two separate tracks of MH RRTP.
The original data included the date of admission and discharge, the pre and post
treatment BAI, BDI-II, and BAM scores, and the ages of the veterans. The data were
divided and coded into five age groups and three lengths-of-stay groups. The BDI-II and
BAI pre and post scores were analyzed based on these groups. Minimal range scores on
the admission measurements for the BDI-II (0-13) and BAI (0-9) were excluded to allow
for a more accurate measure of symptom improvement among veterans with depression
and anxiety.
The necessary sample size was calculated using G*Power 3.1.9.2 (Faul,
Erdfelder, Lang, & Buchner, 2007), which is widely known to be an accurate and
respected manner of identifying appropriate sample sizes. A sample size analysis was
conducted for the intended analysis, a repeated measures within-between ANOVA. For a
repeated measures within-between ANOVA with a medium effect size (f = 0.25), an
alpha level of 0.05, a power of .95, five groups, and pre and post treatment measures, the
minimum sample size necessary to achieve statistical validity was 80 participants.
Specifically, at least 16 participants per group were necessary for the age categories, and
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approximately 27 per group were necessary for the length of stay categories. All usable
cases were analyzed for the purposes of this study, establishing a robust sample size.
Data Collection Procedure
Archival (or secondary) data for this study were used from the Saint Cloud VA
MH RRTP. These data were collected during 2016 and 2017 using the self-report
measures of the BDI-II, BAI, and BAM, as part of the Veterans Integrated Service
Network (VISN) 23 (there are 23 total VISNs in the VA system). This service is
maintained by VA Midwest Health Care Network Managerial Cost Accounting &
Analytics (MCAA), including several of the instrument scores from MH RRTP data.
The MCAA software that is used by the VA is a product from Lexmark Enterprise
Services and Perceptive Software's Acuo Vendor Neutral Archive (VNA), and it
consolidates data from eight different states. It is maintained by program analysts, a
program manager, and a program operations manager employed by the VA throughout
VISN 23. Within these data are self-report measure outcomes, including the BDI-II, BAI,
and BAM, that include measures at the start of treatment and again at completion. In
order to review the data, approval must be granted by the VA Institutional Review Board
(IRB). This study was approved by the VA IRB (Appendix A) and Walden University
IRB (approval # 09-20-18-0499295).
Data collection from the participants occurred within the first 3 days of arrival to
MH RRTP. Upon arriving to the MH RRTP, veterans were scheduled for an orientation
and outcome group, where they were given several instruments to complete, including the
BDI-II, BAI, and BAM. However, if a veteran did not attend this group (forgot or
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disregarded it on his or her schedule) the pretest measure would not be collected, which
would render any posttest results for that veteran as unusable in this study. Veterans who
attended the group provided informed consent, completed a paper form for these
instruments, and included their names and the last four digits of their social security
numbers as identification. The information on the BDI-II, BAI, and BAM instruments
was included in veterans’ charts and inputted via the Mental Health Graphical User
Interface (GUI), which is a program in the Computerized Patient Record System (CPRS)
chart that allows for input of numerous specific instruments and is stored via the MCAA.
A Social Services Assistant (SSA) working in MH RRTP also inputted the BDIII, BAI, and BAM scores into an Excel document kept under a locked password. The
paper versions of these instruments were then shredded. The same procedure was used
for the discharge process; veterans attended the outcome group one to two days before
discharge and completed the BDI-II, BAI, and BAM once again, after which the
information was included in their charts and the Excel document and the paper form was
shredded. This data have not been previously published or used for purposes outside the
facility.
Instrumentation
Three specific self-report measures were used in this study to analyze outcomes in
the MH RRTP: the BDI-II, BAI, and BAM (protective factors scores), which are relevant
to the symptoms and problems that are most represented in the members of the veteran
population who seek services at the MH RRTP. Permission to use the instruments within
this study was granted by the publishers (Appendices B and C).
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Beck Depression Inventory-II
The BDI-II (Subica et al., 2014) is a 21-item self-report measurement tool that
specifically addresses depressive symptoms. This widely used instrument was first
established in 1961 (Beck, Mendelson, Mock, & Erbaugh, 1961) as the BDI with
numerous studies and evaluations since that time (Beck, Steer, & Garbin, 1988; Lopez,
Pierce, Gardner, & Hanson, 2013; Steer, Ball, Ranieri, & Beck, 1999) to eventually
become the BDI-II. Questions on the BDI-II focus on areas such as difficulty with sleep,
suicidal thoughts, feelings of worthlessness and guilt, loss of pleasure, agitation, fatigue,
loss of appetite, and concentration problems (Subica et al., 2014). Scores may range from
0 to 63. Scores ranging from 0 to 13 represent minimal symptoms, while 14 to 19 is the
mild range, 20 to 28 is moderate, and over 28 is the severe category (Subica et al., 2014).
The instrument takes approximately 10 minutes to complete and requires a fifth- to sixthgrade reading level.
The internal consistency for this instrument ranges from .73 to .92 (Beck, Steer, et
al., 1988) and has strong support as a screening instrument for overall depressive
symptoms (Subica et al., 2014). In a study of 575 adult participants receiving treatment in
an outpatient facility, numerous tests for validity and reliability for the BDI-II were
completed (Subica et al., 2014). Researchers reported that the BDI-II total score strongly
correlated with the Behavior and Symptom Identification Scale (BASIS)-24
Depression/Functioning subscale (r = .79, p < .001) and the BASIS-24 overall score (r =
.82, p < .001), demonstrating likely convergent validity. Discriminant validity was
suggested via intercorrelations between the BDI-II total score and the BASIS-24
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substance abuse (r =.13, p < .001) and psychosis (r = .24, p < .001) measures (Subica et
al., 2014). The BDI-II has demonstrated validity and reliability when administered to the
veteran population. A retrospective study completed by Palmer et al. (2012) was
completed with a sample of 310 veterans who had been administered the BDI-II as part
of an evaluation for depression in an outpatient VA polytrauma clinic. The researchers
(Palmer et al., 2012) reported a high level of reliability (a = 0.93) for this veteran sample,
with a mean BDI-II total score of 21.20 (SD = 11.76; range = 0–51).
Beck Anxiety Inventory
The BAI is a 21-item self-report measurement that focuses on various symptoms
of anxiety, including loss of interest and enjoyment, feeling tense, panic, restlessness, and
overall worrying thoughts (Bardhoshi, Duncan, & Erford, 2016). The BAI was initially
developed in 1988 (Beck, Epstein, Brown, & Steer, 1988), and in 1993 a revised manual
was published. The BAI has a potential score of 0 to 63, with minimal symptoms in the
0-to-9 range, mild to moderate symptoms in the 10-to-18 range, moderate to severe in the
19-to-29 range, and severe symptoms in the 30-to-63 range.
An extensive meta-analysis reviewing 192 studies from 1993 to 2013 concluded
that the BAI has strong internal consistency, test–retest reliability, and structural validity
(Bardhoshi et al., 2016). Specifically, when the results from 117 studies were combined
with a sample size of 43,932 participants to determine consistency, an alpha of .91 was
found. To determine test-retest reliability, the researchers were able to use 18 of the
studies and weight them (2,800 total participants) to yield a coefficient of .65 (Bardhoshi
et al., 2016). In testing for convergent validity, the Pearson r ranged from .24 to .81
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(Bardhoshi et al., 2016). The authors determined that given these scores, the BAI largely
demonstrates a high level of validity and reliability as an instrument.
Brief Addiction Monitor
The BAM is a 17-item self-report measure developed by researchers affiliated
with the Center of Excellence in Substance Abuse Treatment and Education (CESATE)
and the VA (Cacciola et al., 2013). Two of the questions on the BAM have subsets
depending on the answer to the initial item. For example, the questionnaire asks about use
of certain substances, and with a “yes” answer, it then expands on additional types of
substances. The BAM provides information regarding perceptions of physical health, use
of substances, cravings, confidence level for not using substances, impact of religion or
spirituality on recovery, and overall satisfaction in progress toward recovery goals
(Cacciola et al., 2013). There is a specific focus and identification upon tallying the
results that notes the risk factors and protective factors scores. This provides an overall
understanding of how participants perceive their recovery and allows a clinician to gain
more knowledge regarding areas of concern. It is noteworthy to recognize that there are
several variations of the BAM, including the BAM-C, which is open-ended rather than
having specific answers to choose from, and the Brief Addiction Monitor-Intensive
Outpatient (BAM-IOP), which uses a 7-day reference rather than the 30-day reference of
the original BAM. The MH RRTP uses the BAM-IOP, which generally asks about the
past 7 days and confidence over the next week to maintain sobriety/recovery-oriented
practices.
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A disadvantage of the BAM is that because it is a relatively new instrument, there
are only a few studies that have investigated its psychometrics. However, it is being used
regularly within the VA for the determination of substance abuse treatment effectiveness
and is one of the main instruments for MH RRTP, in addition to the BAI and BDI-II.
Cacciola et al. (2013) developed the BAM after noting shortcomings with
previous instruments used to assess change during SUD treatment. The researchers
completed this endeavor in two phases, which included actual instrument development
followed by a study to determine psychometric properties. The authors completed the
study by enlisting 175 patients at a VA outpatient substance abuse treatment program.
They reported (Cacciola et al., 2013) support for the BAM as having good test-retest
reliability and predictive validity.
Another study examining the validity and reliability of the BAM was completed
with 810 veterans in a Midwestern VA substance abuse treatment program (Nelson,
Young, & Chapman, 2014). It is noted that these researchers used a slightly different
version of the BAM (the discrete form or BAM-D), whereas the Cacciola et al. (2013)
study used the BAM-C (continuous form). The primary difference between the two
measures is that the items on the BAM-C use a continuous response, while the BAM-D
uses a Likert-type scale response, which is consistent with the BAM used in MH RRTP.
The study by Nelson et al. (2014) reported that the BAM-D lacked a reliable factor
structure; however, the authors also reported that the risk/use questions appeared to be
reliable when analyzed separately. These measures also were reported to have an
acceptable level of divergent and convergent validity. Further, they noted that none of the
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instruments used in this study, including the BAM-D, were reliable predictors of program
completion (Nelson et al., 2014). However, this variable was not addressed in the MH
RRTP study, as the primary focus for use of the BAM was a comparison of the protective
factors scores at the start and end of treatment.
The MH RRTP study, using the BAM-IOP, included the tally of responses to the
protective factors questions (Items 9, 10, 12, 13, 14, 16) that were compared at the start
and end of treatment. The developers (DePhilippis & McKay, n.d.) recommended
comparing the protective factors scores at the start and end of treatment as this provides
an overview of participants’ perceptions of their recovery and ability to maintain
recovery-oriented activities and attitudes, with the goal being that the score increases by
the end of treatment. A high score indicates greater protective factors, with the range of 0
to 24. The protective factors questions include information about attendance of self-help
meetings, confidence in not using alcohol or drugs over the next 7 days, religion or
spirituality supporting recovery, time spent at work, school, or volunteering, whether
enough legally gained income is available, and if supportive friends or family had been
contacted within the past 7 days. The developers assert, among other benefits, the BAM
can determine effectiveness of interventions, one of the primary goals of this MH RRTP
study (DePhilippis & McKay, n.d.).
Variables
In this study, the independent variables were the ages of the veterans (21-30 years
old, 31-40, 41-50, 51-60 and over 60 years of age) and the length of stay in treatment (33
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or less days, 34-46 days, and 47 or more days). The dependent variables were the scores
from the BDI-II, BAI, and BAM (protective factors measurement).
Research Questions and Hypotheses
There are questions related to how residential treatment may benefit the general
veteran population, if there are differences among the various age groups served, and
whether length of stay significantly impacts symptom reduction. These questions and
concerns have guided the research questions for this MH RRTP study, which included:
Research Question 1: Are there differences in veterans’ outcomes for overall
depression symptoms from pre and post treatment based on length of stay (33 or fewer
days, 34-46 days, and 47 or more days) in MH RRTP?
H01:

There is no statistically significant difference in veterans’ outcomes for
overall depression symptoms from the start of treatment to completion
based on length of stay (33 or fewer days, 34-46 days, and 47 or more
days) in MH RRTP.

HA1: There is a statistically significant difference in veterans’ outcomes for
overall depression symptoms from the start of treatment to completion
based on length of stay (33 or fewer days, 34-46 days, and 47 or more
days) in MH RRTP.
Research Question 2: Are there differences in veterans’ outcomes for overall
anxiety symptoms from pre and post treatment based on length of stay (33 or fewer days,
34-46 days, and 47 or more days) in MH RRTP?
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H02:

There is no statistically significant difference in veterans’ outcomes for
overall anxiety symptoms from the start of treatment to completion based
on length of stay (33 or fewer days, 34-46 days, and 47 or more days) in
MH RRTP.

HA2: There is a statistically significant difference in veterans’ outcomes for
overall anxiety symptoms from the start of treatment to completion based
on length of stay (33 or fewer days, 34-46 days, and 47 or more days) in
MH RRTP.
Research Question 3: Are there differences in veterans’ protective factors scores
from pre and post treatment based on veterans’ length of stay?
H03:

There is no statistically significant difference in veterans’ protective
factors scores from pre and post treatment based on veterans’ length of
stay.

HA3: There is a statistically significant difference in veterans’ protective factors
scores from pre and post treatment based on veterans’ length of stay.
Research Question 4: Are there differences in veterans’ outcomes for overall
depression symptoms from pre and post treatment based on veterans’ age groups?
H04:

There is no statistically significant difference in veterans’ outcomes for
overall depression symptoms from pre and post treatment based on
veterans’ age groups.
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HA4: There is a statistically significant difference in veterans’ outcomes for
overall depression symptoms from pre and post treatment based on
veterans’ age groups.
Research Question 5: Are there differences in veterans’ outcomes for overall
anxiety symptoms from pre and post-treatment based on veterans’ age groups?
H05:

There is no statistically significant difference in veterans’ outcomes for
overall anxiety symptoms from pre and post treatment based on veterans’
age groups.

HA5: There is a statistically significant difference in veterans’ outcomes for
overall anxiety symptoms from pre and post treatment based on veterans’
age groups.
Research Question 6: Are there differences in veterans’ protective factors scores
from pre and post treatment based on veterans’ age groups?
H06:

There is no statistically significant difference in veterans’ protective
factors scores from pre and post treatment based on veterans’ age groups.

HA6: There is a statistically significant difference in veterans’ protective factors
scores from pre and post treatment based on veterans’ age groups.
Research Design and Rationale
A descriptive quantitative retrospective study, utilizing secondary data, was
conducted. The rationale for use of this design includes being able to investigate an
outcome that has already occurred and identifying potential associations among variables.
However, it does not allow the variables to be manipulated (Salkind, 2010). Advantages
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of this type of study include a quick and simple analysis procedure, the ability to use
already-established databases, and the need for fewer participants than other types of
studies. It is also applicable when experimental research has been deemed unethical
(Salkind, 2010). For veterans participating in MH RRTP it would be unethical to not
provide the treatment they are requesting in order to have a control group that does not
receive the intervention. Disadvantages of a retrospective quantitative study include
difficulty with risk bias, confounding variables, and lack of control groups. The goal of
the study was to determine an overall level of effectiveness of the MH RRTP, following
program completion while also determining any differences in outcomes for age groups
and lengths of stay in treatment. To achieve this, the most reasonable manner of data
analysis was to utilize information that has already been gathered.
Data Analysis
IBM Statistical Package for the Social Sciences (SPSS) was used to analyze all
data in this study. Following VA and Walden IRB approval, the Excel spreadsheets
containing the data were opened in SPSS, which includes the BAI, BDI-II, and BAM
scores from the MCAA data. The scores of all irregular discharges were removed,
followed by scores for individuals consecutively attending the co-occurring disorders
track and PTSD track (influencing a significant increase in length of stay). Finally, the
scores of individuals who did not complete at least one measure (for both pretreatment
and discharge) were also removed. This left a total of 1,136 usable cases from the
original 2,631 cases. This number exceeded the established minimum sample size
necessary.
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Prior to conducting the analyses to address the research questions, descriptive
statistics were calculated for BDI-II, BAI, and BAM (protective factors) scores from
beginning to end of treatment, treatment length of stay, and age groups. The following
age groups were created based on participants’ reported ages in the dataset: 21-30, 31-40,
41-50, 51-60 and over 60. The length of stay categories included participants who stayed
33 or fewer days, those who stayed 34-46 days, and those who were in programming 47
or more days. Means and standard deviations for pre and post treatment scores were
calculated for the BDI-II, BAI, and BAM protective factors scores. Frequencies and
percentages were calculated for length of stay categories and age groups.
An internal reliability analysis was conducted for BDI-II, BAI, and BAM
(protective factors). Cronbach’s alpha coefficients of reliability was calculated for each
score to establish internal consistency of each composite score. George and Mallery’s
(2016) rule of thumb was applied to assess the reliability of each score where coefficients
greater than 0.7 indicate acceptable reliability.
Analysis of Variance (ANOVA) tests were conducted to address the research
questions. ANOVA provides an accurate method to determine effects of categorical
independent variables on one continuous dependent variable, as well as potential
interaction effects (Warner, 2013). Specifically, the researcher conducted six one-within
one-between, or mixed model, ANOVAs. Mixed model ANOVAs are appropriate when
the researcher intends to assess differences in two or more mutually exclusive groups on
a continuous dependent variable that has been measured at multiple time points
(Tabachnick & Fidell, 2013). The F statistic was used to test the presence of differences
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in group means for the continuous variables. The test allows for analysis of differences in
scores by the main effects of time and group, and the interaction of time and group
(Pagano, 2010). The researcher conducted mixed model ANOVAs to assess differences
in overall depression symptoms, overall anxiety symptoms, and protective factors from
pre to post-intervention by length of stay and age groups.
Prior to conducting the mixed model ANOVA, the researcher assessed the
assumptions of the analysis. Assumptions of ANOVA (Warner, 2013) include: the
dependent variable contains continuous data, both the within-subjects and betweensubjects variables contain at least two categorical related groups, normal distribution of
the dependent variable, no significant outliers, independent observations, homogeneity of
variances, sphericity, and the variance of the dependent variable is approximately the
same in each population. The MH RRTP study design met the ANOVA assumptions.
Finally, post hoc analyses were conducted for statistically significant results,
along with post hoc Tukey HSD tests. Tukey’s test is used when there are three or more
groups being investigated and can assist in decreasing the possibility of a Type I error
(Green & Salkind, 2014). Additionally, paired t-tests were conducted between each
repeated measurement and within each category of length of stay to examine the withinsubjects effects. This combination of statistical tests allowed for differences in the BDIII, BAI, and BAM protective factors scores to be detected accurately.
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Limitations
External Validity Limitations
There are general limitations to external validity in this study. This primarily
includes the lack of generalizability to the larger population. The results of this study
only apply to veterans with co-occurring disorders who participate in residential
treatment within the VA system. Since this study used a descriptive quantitative
retrospective design, a true cause and effect cannot be established as it was not possible
to manipulate the variables in this study. While the study does not allow for overall
generalizability to the entire population, it can provide key information about the
program effectiveness for the veterans who have participated in the program.
Internal Validity Limitations
There are several internal validity limitations that must be considered for this
study. The first is related to fidelity of the interventions. The MH RRTP clinicians are
trained to facilitate the core groups of CBT and SCMI in a similar manner with the
material being consistent in all groups, but personality and therapeutic styles may impact
the outcomes to a certain extent. Additionally, while all veterans in MH RRTP receive
the core groups of SCMI and CBT, there are elective groups that some attend, which
focus on other areas of concern, such as guilt/shame issues, emotions, and relationships.
Therefore, this study was exploratory and focused primarily on the overall outcomes of
participating and completing the program with regards to the length of stay and age group
variables.
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Additional limitations of this exploratory study include the lack of examining
long-term treatment outcomes of MH RRTP, instead focusing specifically on treatment
impact at program completion. Future studies may investigate outcome differences based
on the selection of elective groups, as well as differences among the MH RRTP teams
(which are based on diagnosis and severity of symptoms), types of substances abused,
outcome differences with genders and ethnicities/races, and long-term effects.
Additionally, there is the risk of social desirability bias, a type of response that occurs
when participants answer questions on self-report questionnaires in a way that makes
them appear to be functioning better (than how they really are doing). However, this
often occurs when participants are actively involved in a research study and may be less
likely with archival data. It also does not account for individuals who did not complete
both the pre and posttest for the depression, anxiety, and substance abuse measures,
referred to as attrition bias (Salkind, 2010). It would be beneficial for future studies to
examine potential reasons for not completing the posttest questionnaires. Veterans may
have preferred not to answer the questions, missed the outcome group (completed close
to admission and again at discharge), or left the program due to an irregular discharge.
Investigating the reasons behind irregular discharges may also provide useful
information.
Finally, a limitation that should be considered relates to the potential of
depression symptoms decreasing due to duration of sustained abstinence during
residential treatment. This has been studied in previous research, including via a metaanalysis of 22 studies from 1980 to 2014 (Foulds, Adamson, Boden, Williman, &
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Mulder, 2015). While there is sometimes an increase in depression symptoms during
early withdrawal, this meta-analysis demonstrated that there may be a correlation
between symptoms and duration of sobriety, often during the first three to six weeks of
treatment (Foulds et al., 2015).
Summary
The descriptive quantitative retrospective design allowed for an exploratory study
of the effectiveness of the MH RRTP at the Saint Cloud VA. In completing this study,
additional information is available regarding the impact of this treatment on veterans who
have mental health and/or substance abuse (co-occurring) disorders, while specifically
investigating potential differences in length of stay and age variables. This information
will be used for program improvement and pave the way for further studies to be
completed, such as the impact of specific groups or interventions, in addition to the
overall program effectiveness, and investigating long-term outcomes for MH RRTP.
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Chapter 4: Results
Introduction
Through this descriptive quantitative retrospective study, I sought to examine
whether participation in the MH RRTP at the Saint Cloud VA impacted a decrease in
depression and anxiety while improving protective factors for recovery for individuals
who participated in 2016 and 2017. The specific variables of age and length of stay were
studied via archival data. Veterans completed the BDI-II, BAI, and BAM at the start and
end of treatment to measure the impact of the MH RRTP service delivery model. This
information may be useful for staff of the program and other VA residential facilities to
consider in program development.
Prior to completing the ANOVAs, Cronbach’s alpha coefficients were calculated
for the BAI, BDI-II, and BAM using the guidelines suggested by George and Mallery
(2016), which specify > .9 excellent, > .8 good, > .7 acceptable, > .6 questionable, > .5
poor, and ≤ .5 unacceptable. The full datasets for the 2016 data were available and were
used to determine Cronbach’s alpha coefficients. Unfortunately, the 2017 data only
included final scores (rather than individual items), including a tally for the protective
factors, BDI-II, and BAI. In the 2016 data, the items for the admission BAI had a
Cronbach's alpha coefficient of 0.93, indicating excellent reliability. The items for the
admission BDI-II had a Cronbach’s alpha coefficient of 0.92, also indicating excellent
reliability. The items for the admission BAM had a Cronbach’s alpha coefficient of 0.74,
indicating acceptable reliability. For the discharge BAI, the Cronbach’s alpha coefficient
was 0.94, indicating excellent reliability. The items for the discharge BDI-II had a
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Cronbach’s alpha coefficient of 0.92, indicating excellent reliability. The items for the
discharge BAM had a Cronbach’s alpha coefficient of 0.44, indicating unacceptable
reliability.
A descriptive quantitative retrospective study was chosen because it allowed for
an understanding of differences in BDI-II, BAI, and BAM protective factors scores from
the start to completion of treatment by using archival data. This chapter addresses the
results from the six research questions and analyses that were conducted. The research
questions and hypotheses, which are addressed individually, were as follows:
Research Question 1: Are there differences in veterans’ outcomes for overall
depression symptoms from pre and post treatment based on length of stay (33 or fewer
days, 34-46 days, and 47 or more days) in MH RRTP?
H01:

There is no statistically significant difference in veterans’ outcomes for
overall depression symptoms from the start of treatment to completion
based on length of stay (33 or fewer days, 34-46 days, and 47 or more
days) in MH RRTP.

HA1: There is a statistically significant difference in veterans’ outcomes for
overall depression symptoms from the start of treatment to completion
based on length of stay (33 or fewer days, 34-46 days, and 47 or more
days) in MH RRTP.
Research Question 2: Are there differences in veterans’ outcomes for overall
anxiety symptoms from pre and post treatment based on length of stay (33 or fewer days,
34-46 days, and 47 or more days) in MH RRTP?
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H02:

There is no statistically significant difference in veterans’ outcomes for
overall anxiety symptoms from the start of treatment to completion based
on length of stay (33 or fewer days, 34-46 days, and 47 or more days) in
MH RRTP.

HA2: There is a statistically significant difference in veterans’ outcomes for
overall anxiety symptoms from the start of treatment to completion based
on length of stay (33 or fewer days, 34-46 days, and 47 or more days) in
MH RRTP.
Research Question 3: Are there differences in veterans’ protective factors scores
from pre and post treatment based on veterans’ length of stay?
H03:

There is no statistically significant difference in veterans’ protective
factors scores from pre and post treatment based on veterans’ length of
stay.

HA3: There is a statistically significant difference in veterans’ protective factors
scores from pre and post treatment based on veterans’ length of stay.
Research Question 4: Are there differences in veterans’ outcomes for overall
depression symptoms from pre and post treatment based on veterans’ age groups?
H04:

There is no statistically significant difference in veterans’ outcomes for
overall depression symptoms from pre and post treatment based on
veterans’ age groups.
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HA4: There is a statistically significant difference in veterans’ outcomes for
overall depression symptoms from pre and post treatment based on
veterans’ age groups.
Research Question 5: Are there differences in veterans’ outcomes for overall
anxiety symptoms from pre and post treatment based on veterans’ age groups?
H05:

There is no statistically significant difference in veterans’ outcomes for
overall anxiety symptoms from pre and post treatment based on veterans’
age groups.

HA5: There is a statistically significant difference in veterans’ outcomes for
overall anxiety symptoms from pre and post treatment based on veterans’
age groups.
Research Question 6: Are there differences in veterans’ protective factors scores
from pre and post treatment based on veterans’ age groups?
H06:

There is no statistically significant difference in veterans’ protective
factors scores from pre and post treatment based on veterans’ age groups.

HA6: There is a statistically significant difference in veterans’ protective factors
scores from pre and post treatment based on veterans’ age groups.
Descriptive Data
The veterans in this study were admitted to the MH RRTP between January 1,
2016 and December 31, 2017 and completed the program successfully. The number of
participants was reduced to 1,136 from an original group of 2,631 veterans after
eliminating those who discharged with irregular status (prior to their agreed-upon
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completion date) or participated in concurrent treatment episodes of care (transferring
directly from the co-occurring disorders track to the PTSD track). The length of stay
groups were divided into three categories: 33 or fewer days (Group 1), 34-46 days
(Group 2), and 47 or more days (Group 3). The age groups were divided into five
categories: 21-30 (Group 1), 31-40 (Group 2), 41-50 (Group 3), 51-60 (Group 4), and 61
and over (Group 5). Summary statistics were calculated for each interval and ratio
variable. Frequencies and percentages were calculated for each nominal variable. The
most frequently observed category for the number of days in programming was 34-46
days (n = 433, 38%). The most frequently observed category for age groups was ages 5160 (n = 363, 32%). Frequencies and percentages for length of stay and age group are
presented in Table 1.
Table 1
|Frequencies and Percentages for Length of Stay and Age Groups
Variable
Length of stay
1 (33 days or fewer)
2 (34-46 days)
3 (47 or more days)
Age groups
1 (21-30)
2 (31-40)
3 (41-50)
4 (51-60)
5 (61 and over)

n

%

352
433
351

30.99
38.12
30.90

122
241
191
363
219

10.74
21.21
16.81
31.95
19.28

Note. Due to rounding errors, percentages may not equal 100%.
Minimal range scores on the admission measurements for the BDI-II (0-13) and
BAI (0-9) were excluded to allow for a more accurate measure of symptom improvement
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among veterans with depression and anxiety. After removing the minimal range scores,
the average depression score (BDI-II) at admission was 23.58 (SD = 13.30) and at
discharge was 12.62 (SD = 11.72). The average anxiety score (BAI) at admission was
16.21 (SD = 11.90) and at discharge was 10.45 (SD = 10.21). The average protective
factors (from the BAM) score at admission was 11.98 (SD = 4.08) and at discharge was
13.18 (SD = 4.16). Skewness and kurtosis were also calculated, and it was noted that
none of the skewness and kurtosis values exceeded the critical values. Table 2 presents
the summary statistics table means, standard deviations, and number of participants for
the admission and discharge scores.
Table 2
Summary Statistics Table for Interval and Ratio Variables
Variable

M

SD

n

Admission depression scores

23.58

13.30

1,055

Admission anxiety scores

16.21

11.90

1,054

Admission protective factors scores

11.98

4.08

979

Discharge depression scores

12.62

11.72

1,093

Discharge anxiety scores

10.45

10.21

1,098

Discharge protective factors scores

13.18

4.16

966

Results of the Study
Each research question and corresponding hypotheses are addressed in this
section. A total of six one-within one-between, or mixed model, ANOVAs were
conducted. For each ANOVA, the assumptions of univariate normality,
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homoscedasticity, outliers, and sphericity were assessed. However, the usual sphericity
assumption does not apply when there are only two repeated measurements. Additionally,
normality was evaluated for each ANOVA using a Q-Q scatterplot (Bates, Mächler,
Bolker, & Walker, 2014; DeCarlo, 1997; Field, 2009). This method compares the
distribution of the residuals with a normal distribution (a theoretical distribution that
follows a bell curve). A fairly normal distribution is indicated with a straight, solid line.
For each test, Mahalanobis distances were calculated on the residuals and compared to a
χ2 distribution (Newton & Rudestam, 2012) to identify influential points. An outlier was
defined as any Mahalanobis distance that exceeded 10.83, the .999 quantile of a χ2
distribution with 1 degree of freedom. Outliers in the data that met these criteria were
subsequently removed from the analysis. Additionally, post-hoc analyses were completed
for results that indicated potential significance in scores on the BDI-II, BAI, and/or BAM
from admission to discharge.
Results for Research Question 1
Research Question 1: Are there differences in veterans’ outcomes for overall
depression symptoms from pre and post treatment based on length of stay (33 or fewer
days, 34-46 days, and 47 or more days) in MH RRTP?
H01:

There is no statistically significant difference in veterans’ outcomes for
overall depression symptoms from the start of treatment to completion
based on length of stay (33 or fewer days, 34-46 days, and 47 or more
days) in MH RRTP.
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HA1: There is a statistically significant difference in veterans’ outcomes for
overall depression symptoms from the start of treatment to completion
based on length of stay (33 or fewer days, 34-46 days, and 47 or more
days) in MH RRTP.
Analysis for Depression and Length of Stay
A mixed model analysis of variance (ANOVA) with one within-subjects factor
and one between-subjects factor was conducted to determine whether significant
differences existed in pretreatment depression scores and discharge depression scores
using the BDI-II between the levels of length of stay. Prior to the analysis, the
assumptions of univariate normality, homoscedasticity, and absence of outliers were
assessed. The assumption of normality was evaluated using a Q-Q scatterplot (Bates et
al., 2014; DeCarlo, 1997; Field, 2009) and was met as indicated by the Q-Q scatterplot as
presented in Figure 1. The assumption of homoscedasticity was met as demonstrated by
the scatterplot in Figure 2. Two outliers were removed from this test using the
Mahalanobis distances calculation.
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Figure 1. Q-Q scatterplot testing normality.

Figure 2. Residuals scatterplot testing homoscedasticity.
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Results for Depression and Length of Stay
The main effect for length of stay was not significant F(2, 321) = 0.91, p = .404,
indicating that the depression scores were similar across categories of length of stay. The
main effect for the within-subjects factor was significant, F(1, 321) = 169.14, p < .001,
indicating that there were significant differences between the values of admission
depression scores and discharge depression scores on the BDI-II. The interaction effect
between the within-subjects factor and length of stay was significant F(2, 321) = 3.96, p
= .020, indicating differences in depression scores from admission to discharge by length
of stay categories. Due to this significant interaction effect, the null hypothesis was
rejected for Research Question 1. Table 3 presents the ANOVA results, Table 4 presents
means and standard deviations for each factor level combination and row and column
totals, and Figure 3 displays the depression admission and discharge score means by
length of stay.
Table 3
ANOVA Results for Depression and Length of Stay

Source
Between-subjects
Length of stay
Residuals
Within-subjects
Within factor
Length of stay: Within
Residuals

SS

df

MS

F

p

ηp2

258.06
45511.18

2
321

129.03
141.78

0.91

.404

0.01

8030.81
376.15
15241.23

1
2
321

8030.81
188.07
47.48

169.14
3.96

< .001
.020

0.35
0.02
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Table 4
Means and Standard Deviations for Length of Stay and Depression Scores
Admission depression
scores

Discharge depression
scores

Row
average

M (SD)

M (SD)

M (SD)

≤ 33 days
(Group 1)

32.55 (9.55)

27.70 (9.90)

30.12
(9.99)

34-46 days
(Group 2)

33.47 (10.06)

24.97 (8.44)

29.22
(10.20)

≥ 47 days (Group 3)

34.69 (10.21)

26.66 (10.14)

30.68
(10.92)

Column average

33.66 (9.99)

26.30 (9.50)

29.98
(10.41)

Length of stay

Figure 3. Depression admission and discharge means by length of stay.
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Post-Hoc Tests for Depression and Length of Stay
Post-hoc tests were conducted to further explore the significant effects; paired ttests were conducted between each repeated measurement and within each category of
length of stay group to examine the within-subjects effects. The overall mean for
admission depression was significantly larger than for the posttest depression scores, t =
13.47, p < .001. For all length of stay groups, the admission scores were significantly
larger at admission than at discharge on the BDI-II, with the first group (shortest length
of stay), t = 4.83, p < .001, the second group (moderate length of stay), t = 10.12, p < .001
and the longest length of stay, t = 8.23, p < .001. To determine between-subject effects,
Tukey comparisons were conducted for each repeated measurement using length of stay
as the independent variable to examine the between-subjects effects with no further
significant differences found.
Results for Research Question 2
Research Question 2: Are there differences in veterans’ outcomes for overall
anxiety symptoms from pre and post treatment based on length of stay (33 or less days,
34-46 days, and 47 or more days) in MH RRTP?
H02:

There is no statistically significant difference in veterans’ outcomes for
overall anxiety symptoms from the start of treatment to completion based
on length of stay (33 or less days, 34-46 days, and 47 or more days) in MH
RRTP.

HA2: There is a statistically significant difference in veterans’ outcomes for
overall anxiety symptoms from the start of treatment to completion based
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on length of stay (33 or less days, 34-46 days, and 47 or more days) in MH
RRTP.
Analysis for Anxiety and Length of Stay
A mixed model analysis of variance (ANOVA) with one within-subjects factor
and one between-subjects factor was conducted to determine whether significant
differences exist in admission and discharge anxiety scores on the BAI between the levels
of length of stay. Prior to the analysis, the assumptions of univariate normality,
homoscedasticity, and absence of outliers were assessed. The assumption of normality
was evaluated using a Q-Q scatterplot (Bates et al., 2014; DeCarlo, 1997; Field, 2009)
and was met as indicated by the Q-Q scatterplot as presented in Figure 4. The assumption
of homoscedasticity was met as demonstrated by the scatterplot in Figure 5. Five outliers
were removed from this test using the Mahalanobis distances calculation.

Figure 4. Q-Q scatterplot testing normality.
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Figure 5. Residuals scatterplot testing homoscedasticity.
Results for Anxiety and Length of Stay
The main effect for length of stay was not significant F(2, 349) = 1.67, p = .190,
indicating the values of length of stay were all similar. The main effect for the withinsubjects factor was significant F(1, 349) = 65.34, p < .001, indicating there were
significant differences between the values of admission anxiety scores and discharge
anxiety scores. The interaction effect between the within-subjects factor and length of
stay was not significant F(2, 349) = 1.50, p = .224, indicating similar values for
admission anxiety scores, discharge anxiety scores, and levels of length of stay. Due to
no interaction effect being present, the null hypothesis was not rejected for Research
Question 2. Table 5 presents the ANOVA results, Table 6 presents means and standard
deviations for each factor level combination and row and column totals, and Figure 6
presents a graph of the admission and discharge anxiety score means by length of stay.
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Table 5
ANOVA Results for Anxiety and Length of Stay
Source
Between-subjects
Length of stay
Residuals
Within-subjects
Within factor
Length of stay: Within factor
Residuals

SS

df

MS

F

p

ηp2

454.32
47439.56

2
349

227.16
135.93

1.67

.190

0.01

3053.17
140.60
16306.71

1
2
349

3053.17
70.30
46.72

65.34
1.50

< .001
.224

0.16
0.01

Table 6
Means and Standard Deviations for Length of Stay and Anxiety Scores
Admission anxiety
scores

Discharge anxiety
scores

Row
average

M (SD)

M (SD)

M (SD)

≤ 33 days
(Group 1)

23.81 (9.15)

20.94 (8.94)

22.37 (9.14)

34-46 days
(Group 2)

25.87 (9.59)

21.08 (9.39)

23.48 (9.77)

≥ 47 days
(Group 3)

26.91 (11.28)

21.92 (8.46)

24.42
(10.26)

Column average

25.71 (10.18)

21.35 (8.93)

23.53 (9.81)

Length of stay
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Figure 6. Admission and discharge anxiety means by length of stay.
Results for Research Question 3
Research Question 3: Are there differences in veterans’ protective factors scores
from pre and post treatment based on veterans’ length of stay?
H03:

There is no statistically significant difference in veterans’ protective
factors scores from pre and post treatment based on veterans’ length of
stay.

HA3: There is a statistically significant difference in veterans’ protective factors
scores from pre and post treatment based on veterans’ length of stay.
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Analysis for Protective Factors and Length of Stay
A mixed model analysis of variance (ANOVA) with one within-subjects factor
and one between-subjects factor was conducted to determine whether significant
differences exist in admission protective factors scores and discharge protective factors
scores between the levels of lengths of stay. Prior to the analysis, the assumptions of
univariate normality, homoscedasticity, and absence of outliers were assessed. Normality
was evaluated using a Q-Q scatterplot (Bates et al., 2014; DeCarlo, 1997; Field, 2009).
The plot indicated that the assumption was met and is presented in Figure 7.
Homoscedasticity was evaluated by plotting the residuals against the predicted values.
The plot indicated that the assumption was met and is presented in Figure 8. Five outliers
were removed from this test using the Mahalanobis distances calculation.

Figure 7. Q-Q scatterplot testing normality.
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Figure 8. Residuals scatterplot testing homoscedasticity.
Results for Protective Factors and Length of Stay
The main effect for length of stay was significant F(2, 899) = 7.28, p < .001,
indicating there were significant differences among the values of length of stay. The main
effect for the within-subjects factor was significant F(1, 899) = 77.93, p < .001,
indicating there were significant differences between the values of admission protective
factors scores and discharge protective factors scores. Additionally, the interaction effect
for the within-subjects factor and length of stay was significant F(2, 899) = 3.10, p =
.045, indicating differences among the values of admission protective factors scores,
discharge protective factors scores, and levels of length of stay. As there was an
interaction effect noted (p = .045), the null hypothesis for research question 3 was
rejected. Table 7 presents the ANOVA results. Table 8 presents means and standard
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deviations for each factor level combination and row and column totals. Figure 9 displays
the admission and discharge protective factor means by length of stay.
Table 7
ANOVA Results for Protective Factors and Length of Stay
Source
Between-subjects
Length of stay
Residuals
Within-subjects
Within factor
Length of stay: Within factor
Residuals

SS

df

MS

F

p

ηp2

338.48
20911.17

2
899

169.24
23.26

7.28

< .001

0.02

775.74
61.74
8949.25

1
2
899

775.74
30.87
9.95

77.93
3.10

< .001
.045

0.08
0.01

Table 8
Means and Standard Deviations for Protective Factors and Length of Stay
Admission protective factors
scores

Discharge protective factors
scores

Row
average

M (SD)

M (SD)

M (SD)

≤ 33 days
(Group 1)

12.75 (4.18)

13.61 (4.16)

13.18
(4.19)

34-46 days
(Group 2)

11.93 (3.70)

13.22 (4.00)

12.58
(3.90)

≥ 47 days
(Group 3)

11.17 (4.26)

12.98 (4.26)

12.07
(4.35)

Column average

11.98 (4.07)

13.28 (4.13)

12.63
(4.15)

Length of stay
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Figure 9. Protective factor means by length of stay.
Post-Hoc Tests for Protective Factors and Length of Stay
Post-hoc tests were conducted to further explore the significant effects. Paired ttests were conducted between each repeated measurement and within each category of
length of stay to examine the within-subjects effects. Overall admission protective factors
scores were significantly smaller than discharge protective factors scores, t = -8.74, p <
.001. For the specific lengths of stay results, Group 1 (shortest length of stay) admission
protective factors scores were significantly smaller than discharge protective factors
scores, t = -3.27, p = .001. For the moderate length of stay (Group 2), admission scores
were also significantly smaller than discharge scores, t = -5.64, p < .001 and for the
longest length of stay (Group 3), admission scores were significantly smaller than
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discharge scores, t = -6.29, p < .001. Tukey comparisons were conducted for each
repeated measurement using length of stay as the independent variable to examine the
between-subjects effects. For the admission protective factors scores, the mean for Group
2 was significantly smaller than Group 1, p = .028 and the mean of the admission
protective factors scores for Group 3 was significantly smaller than group 1, p < .001.
Results for Research Question 4
Research Question 4: Are there differences in veterans’ outcomes for overall
depression symptoms from pre and post treatment based on veterans’ age groups?
H04:

There is no statistically significant difference in veterans’ outcomes for
overall depression symptoms from pre and post treatment based on
veterans’ age groups.

HA4: There is a statistically significant difference in veterans’ outcomes for
overall depression symptoms from pre and post treatment based on
veterans’ age groups.
Analysis for Depression and Age Groups
A mixed model analysis of variance (ANOVA) with one within-subjects factor
and one between-subjects factor was conducted to determine whether significant
differences exist in admission depression scores and discharge depression scores between
the levels of age groups. Prior to the analysis, the assumptions of univariate normality,
homoscedasticity, and absence of outliers were assessed. Normality was evaluated using
a Q-Q scatterplot (Bates et al., 2014; DeCarlo, 1997; Field, 2009). The plot indicated that
the assumption was met and is presented in Figure 10. Homoscedasticity was evaluated

96
by plotting the residuals against the predicted values. The plot indicated that the
assumption was met and is presented in Figure 11. Three outliers were removed from this
test using the Mahalanobis distances calculation.

Figure 10. Q-Q scatterplot testing normality.
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Figure 11. Residuals scatterplot testing homoscedasticity.
Results for Age Groups and Depression
The main effect for age groups was significant F(4, 319) = 4.21, p = .002,
indicating there were significant differences among the values of age groups. The main
effect for the within-subjects factor was significant F(1, 319) = 154.26, p < .001,
indicating there were significant differences between the values of admission depression
scores and discharge depression scores. The interaction effect between the withinsubjects factor and age groups was not significant F(4, 319) = 0.38, p = .822, indicating
similar values for admission depression scores, discharge depression scores, and levels of
age groups. Due to an interaction effect that was not statistically significant (p = .822),
the null hypothesis was not rejected for Research Question 4. Table 9 presents the
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ANOVA results. Table 10 presents means and standard deviations for each factor level
combination and row and column totals. Figure 12 displays the depression admission and
discharge means by age groups.
Table 9
ANOVA Results for Depression and Age Groups
Source
Between-subjects
Age groups
Residuals
Within-subjects
Within Factor
Age groups: Within factor
Residuals

SS

df

MS

F

p

ηp2

2294.56
43474.68

4
319

573.64
136.28

4.21

.002

0.05

7516.20
74.38
15543.00

1
4
319

7516.20
18.59
48.72

154.26
0.38

< .001
.822

0.33
0.00

Table 10
Means and Standard Deviations for Depression Scores and Age Groups
Admission depression
scores

Discharge depression
scores

Row
average

M (SD)

M (SD)

M (SD)

1 (Ages 21-30)

33.14 (10.28)

25.36 (7.26)

29.25 (9.67)

2 (Ages 31-40)

34.79 (9.37)

27.67 (10.72)

31.23 (10.65)

3 (Ages 41-50)

35.94 (11.50)

29.04 (9.74)

32.49 (11.16)

4 (Ages 51-60)

33.26 (8.97)

25.03 (9.06)

29.15 (9.89)

5 (Ages 61+)

29.16 (9.92)

23.05 (8.24)

26.11 (9.56)

Column
average

33.66 (9.99)

26.30 (9.50)

29.98 (10.41)

Age groups
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Figure 12. Depression means by age groups.
Results for Research Question 5
Research Question 5: Are there differences in veterans’ outcomes for overall
anxiety symptoms from pre and post treatment based on veterans’ age groups?
H05:

There is no statistically significant difference in veterans’ outcomes for
overall anxiety symptoms from pre and post treatment based on veterans’
age groups.

HA5: There is a statistically significant difference in veterans’ outcomes for
overall anxiety symptoms from pre and post treatment based on veterans’
age groups.
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Analysis for Anxiety and Age Groups
A mixed model ANOVA with one within-subjects factor and one betweensubjects factor was conducted to determine whether significant differences exist in
admission anxiety scores and discharge anxiety scores between the levels of age groups.
Prior to the analysis, the assumptions of univariate normality, homoscedasticity, and
absence of outliers were assessed. Normality was evaluated using a Q-Q scatterplot
(Bates et al., 2014; DeCarlo, 1997; Field, 2009). The plot indicated that the assumption
was met and is presented in Figure 13. Homoscedasticity was evaluated by plotting the
residuals against the predicted values. The assumption was met and is presented in Figure
14. Five outliers were removed from this test using the Mahalanobis distances
calculation.

Figure 13. Q-Q scatterplot testing normality.
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Figure 14. Residuals scatterplot testing homoscedasticity.
Results for Age Groups and Anxiety
The main effect for age groups was not significant F(4, 347) = 1.61, p = .171,
indicating the values of age groups were all similar. The main effect for the withinsubjects factor was significant F(1, 347) = 65.69, p < .001, indicating there were
significant differences between the values of admission anxiety scores and discharge
anxiety scores. The interaction effect between the within-subjects factor and age groups
was not significant F(4, 347) = 1.99, p = .095, indicating similar values for admission
anxiety scores, discharge anxiety scores, and levels of age groups. For Research Question
5, the null hypothesis was not rejected because the interaction effect was not statistically
significant (p = .095). Table 11 presents the ANOVA results. Table 12 presents means
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and standard deviations for each factor level combination and row and column totals.
Figure 15 displays admission and discharge anxiety means by age groups.
Table 11
ANOVA Results for Anxiety and Age Groups
Source
Between-subjects
Age groups
Residuals
Within-subjects
Within factor
Age groups: Within factor
Residuals

SS

df

MS

F

p

ηp2

873.07
47020.81

4
347

218.27
135.51

1.61

.171

0.02

3043.83
369.72
16077.58

1
4
347

3043.83
92.43
46.33

65.69
1.99

< .001
.095

0.16
0.02

Table 12
Means and Standard Deviations for Anxiety and Age Groups
Admission anxiety scores Discharge anxiety scores
Age groups

Row average

M (SD)

M (SD)

M (SD)

1

25.10 (9.46)

21.32 (10.82)

23.21 (10.29)

2

25.78 (9.61)

22.01 (8.98)

23.89 (9.47)

3

28.82 (12.14)

21.56 (9.88)

25.19 (11.62)

4

25.07 (9.89)

21.23 (7.80)

23.15 (9.09)

5

22.92 (8.75)

19.92 (7.03)

21.42 (8.04)

Column average

25.71 (10.18)

21.35 (8.93)

23.53 (9.81)

103

Figure 15. Anxiety means by age groups.
Results for Research Question 6
Research Question 6: Are there differences in veterans’ protective factors scores
from pre and post treatment based on veterans’ age groups?
H06:

There is no statistically significant difference in veterans’ protective
factors scores from pre and post treatment based on veterans’ age groups.

HA6: There is a statistically significant difference in veterans’ protective factors
scores from pre and post treatment based on veterans’ age groups.
Analysis for Protective Factors and Age Groups
A mixed model ANOVA with one within-subjects factor and one betweensubjects factor was conducted to determine whether significant differences exist in
admission protective factors scores and discharge protective factors scores between the
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levels of age groups. Prior to the analysis, the assumptions of univariate normality,
homoscedasticity, and absence of outliers were assessed. Normality was evaluated using
a Q-Q scatterplot (Bates et al., 2014; DeCarlo, 1997; Field, 2009). The plot indicated that
the assumption was met and is presented in Figure 16. Homoscedasticity was evaluated
by plotting the residuals against the predicted values. The assumption was met and is
presented in Figure 17. Five outliers were removed from this test using the Mahalanobis
distances calculation.

Figure 16. Q-Q scatterplot testing normality.
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Figure 17. Residuals scatterplot testing homoscedasticity.
Results for Age Groups and Protective Factors
The main effect for age groups was not significant F(4, 897) = 1.11, p = .350,
indicating the values of age groups were similar. The main effect for the within-subjects
factor was significant F(1, 897) = 54.40, p < .001, indicating significant differences
between the values of admission and discharge protective factors scores. The interaction
effect between the within-subjects factor and age groups was significant F(4, 897) = 2.59,
p = .036, indicating differences among the values of admission protective factors scores,
discharge protective factors scores, and levels of age groups. For Research Question 6,
the null hypothesis was rejected due to the interaction effect being statistically
significant. Table 13 presents the ANOVA results. Table 14 presents means and standard
deviations for each factor level combination and row and column totals. Figure 18
displays a graph of admission and discharge protective factors means by age groups.
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Table 13
ANOVA Results for Protective Factors and Age Groups
Source
Between-subjects
Age groups
Residuals
Within-subjects
Within factor
Age groups: Within factor
Residuals

SS

df

104.71
4
21144.93 897
540.22
102.86
8908.13

MS

F

p

ηp2

26.18
23.57

1.11

.350

0.00

< .001
.036

0.06
0.01

1 540.22 54.40
4
25.72 2.59
897 9.93

Table 14
Means and Standard Deviations for Protective Factors and Age Groups
Admission protective factors
scores

Discharge protective factors
scores

Row
average

M (SD)

M (SD)

M (SD)

1

12.47 (3.85)

12.54 (3.89)

12.51
(3.86)

2

11.96 (3.83)

13.00 (3.95)

12.48
(3.92)

3

12.13 (4.16)

13.62 (3.78)

12.88
(4.04)

4

11.66 (4.24)

13.18 (4.51)

12.42
(4.44)

5

12.14 (4.05)

13.87 (4.01)

13.01
(4.12)

Column
average

11.98 (4.07)

13.28 (4.13)

12.63
(4.15)

Age groups
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Figure 18. Protective factors means by age groups.
Post-Hoc Tests for Protective Factors and Age Groups
Post-hoc tests were conducted to further explore the significant interaction effects.
Paired t-tests were conducted between each repeated measurement and within each
category of age groups to examine the within-subjects effects. Overall admission
protective factors scores were significantly smaller than discharge protective factors
scores, t = -8.74, p < .001. For the first age group (ages 21-30) no significant differences
were found. For the second age group (31-40) admission protective factors scores were
significantly smaller than discharge protective factors scores, t = -3.38, p < .001. For
Group 3 (ages 41-50) admission protective factors scores were significantly smaller than
discharge protective factors scores, t = -4.20, p < .001. For Group 4 (ages 51-60)
admission protective factors scores were significantly smaller than discharge protective
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factors scores, t = -5.70, p < .001. Lastly, for the oldest group (ages 61 and over)
admission protective factors scores were significantly smaller than discharge protective
factors scores, t = -5.26, p < .001. Tukey comparisons were conducted for each repeated
measurement using age groups as the independent variable to examine the betweensubjects effects. No further significant differences were found for admission, discharge,
or overall for protective factors scores.
Summary
This study utilized six one-within one-between analysis of variance tests
(ANOVA) to determine potential differences in pre and posttest scores from the BDI-II,
BAI, and protective factors from the BAM among veterans attending the Mental Health
Residential Rehabilitation Treatment Program. Overall, the results indicated significant
differences in pre and post-treatment scores on all three instruments, with the notable
exception of very little change among the youngest age group in the protective factors pre
and post-treatment measures. For the majority of the categories, length of stay and age
groups did not significantly impact scores on the BDI-II, BAI, and BAM protective
factors, although it is noted that the anxiety discharge scores for the oldest veterans were
significantly smaller than ages 41-50. However, the older veterans’ admission anxiety
scores were also smaller than the other age groups. In chapter 5, interpretation of the
results will be reviewed, along with the purpose of the study, limitations, implications,
and recommendations for future research.
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Chapter 5: Discussion, Conclusions, and Recommendations
Overview of the Study
The increasing number of veterans experiencing co-occurring substance use and
mental health disorders highlights the importance of appropriate and beneficial treatment
options within the VA system (Kelly & Daley, 2013). Through this study, I sought to
acquire information that might provide insights on the effectiveness of residential
programming that implements the integrated treatment model for the treatment of
numerous disorders and symptoms, including depression, anxiety, and substance abuse.
Potential differences with age groups and lengths of stay in a VA residential
rehabilitation treatment program were examined by comparing pre and posttest scores on
the BDI-II, BAI, and BAM (protective factors).
Interpretation of the Findings
A total of six one-within one-between, or mixed model, ANOVAs were
conducted to determine the impact of age groups and lengths of stay in the residential
treatment program on depression, anxiety, and protective factors scores. There were five
age groups used in this study: ages 21-30, 31-40, 41-50, 51-60, and 61 and over, along
with three length of stay groups: up to 33 days, 34-46 days, and 47 or more days. The
findings and interpretations for each research question are discussed in this section, along
with an overall summary of findings.
Interpretation of Length of stay Outcomes
Research Questions 1, 2, and 3 examined differences in depression, anxiety, and
protective factors outcomes, based on length of stay in a VA residential treatment
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program, from admission to discharge. For the depression outcomes, it was evident that
scores on the BDI-II were significantly decreased from admission to discharge, with
similar scores across the various length of stay categories. While there were no
significant differences found for the pre or post treatment depression scores after a posthoc test for between-subjects factors, the within-subjects factor indicated a statistically
significant interaction between the pre and post treatment BDI-II scores. Specifically,
each length of stay category had noteworthy deductions in the mean score of the BDI-II
from admission to discharge, including the shortest length of stay (from 32.55 to 27.7),
the moderate length of stay (33.47 to 24.97), and the longest length of stay (from 33.66 to
26.3). This indicates that MH RRTP participation was beneficial to veterans in decreasing
overall depression symptoms.
For anxiety outcomes, the overall main effects indicated that BAI scores were
similar across the various lengths of stay, with a significant decrease from pre to post
treatment. However, the interaction effect between length of stay and pre to post
treatment was not statistically significant. These overall scores indicated that veterans
benefitted from the residential program in reducing anxiety symptoms without regard to
the number of days that they were in the program. Specifically, the shortest length of stay
BAI mean scores decreased from 23.81 to 20.94, the moderate length of stay decreased
from 25.87 to 21.08 on mean scores, and the longest length of stay decreased from 26.91
to 21.92.
Finally, for the protective factors outcomes based on the BAM, the main effect for
the within-subjects factor was significant, indicating that there were significant
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differences between the values of admission protective factors scores and discharge
protective factors scores. For all length of stay groups, the admission protective scores
were significantly smaller than the discharge protective factors, indicating that veterans in
the residential program benefitted by increasing their protective strategies to maintain
sobriety and a recovery-oriented outlook. After post-hoc tests were completed for
between-subjects effects, it was noted that the admission scores mean for moderate length
of stay was significantly smaller (11.93) than for the shortest length of stay (12.75), while
the protective factors mean for the longest length of stay was significantly smaller (11.17)
than for the shortest length of stay.
Relating the Results to Previous Literature
A limited number of studies regarding length of stay have been conducted, but the
results have varied. For instance, Coker et al. (2016) determined that length of stay was
correlated with decreased symptom reduction, but the researchers noted that the
improvement might be due to the intensity of the programs rather than the length of stay.
This has some similarities to the MH RRTP study, as veterans can choose to have an
intense treatment experience by being involved in numerous elective groups in addition
to the core required CBT and SCMI groups, or they can attend the minimum
requirements. Coker et al. also discovered that those who were discharged prior to
treatment completion (irregular discharge) had poorer outcomes for abstinence than those
who completed treatment on the discharge date that had been agreed upon during the
admission process. This may lead to the conclusion that the act of completing treatment
by staying until a predetermined completion date may, in itself, impact symptom
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reduction. When a participant completes a goal, such as finishing a treatment episode of
care, self-esteem and confidence can certainly improve, which would be reflected in the
self-report measures. It is possible that scores for the MH RRTP study were impacted in a
similar manner.
In a different study focusing on length of stay outcomes, a meta-analysis of 28
programs with 1,307 participants (Harris et al., 2011) indicated that participants who
stayed more than 90 days demonstrated the least improvement in the Addiction Severity
Index measure. In that meta-analysis, the length of stay categories were divided into 1530, 31-45, 46-60, 61-90, and more than 90 days. However, the current study for the MH
RRTP did not include such long lengths of stay. The MH RRTP data actually indicated
that the longer length of stay for participants was typically 55-60 days, with one noted
outlier of 78 days, an uncommon occurrence in this program. Therefore, the results of the
two past studies are difficult to compare to the current investigation and illustrate the
importance of completing the MH RRTP study, in that there are no similar comparisons
regarding length of stay for VA residential programs treating co-occurring disorders in
the current literature.
Interpretation of Age Group Outcomes
Research Questions 4, 5, and 6 examined differences in depression, anxiety, and
protective factors outcomes, based on age groups, from admission to discharge. For the
depression measures, the results showed that the main effect for age groups and the
within-subjects factors were significant, indicating that there were significant differences
between the scores on the BDI-II from pre to post treatment. However, the interaction
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effect for the within-subjects factor and age groups was not significant. Between-subjects
Tukey comparisons did indicate that the mean admission depression scores for the oldest
group were significantly smaller than for Groups 2 and 3 (ages 31-50) and the discharge
depression scores mean for the oldest participants (Group 5) was significantly smaller
than for Group 3 (ages 41-50). This may indicate that the older veterans identified fewer
depression symptoms at both admission and discharge than some of the other age groups.
With the anxiety outcomes, it did not appear that age had a significant effect on how
much anxiety scores were decreased. Rather, for all groups, the anxiety scores were
significantly reduced from admission to discharge. Finally, for protective factors
outcomes based on age groups, the overall admission scores were significantly smaller
than discharge protective factors scores, which is to be expected, in that a goal of MH
RRTP participation is to increase behaviors, support networks, and other protective
aspects to maintain recovery. Additionally, the interaction effect between the withinsubjects factor and age groups indicated differences among the values of admission
protective factors scores, discharge protective factors scores, and levels of age groups.
For Age Group 1 (ages 21-30) no significant differences were found. For all other age
groups, admission protective factors scores were significantly smaller than discharge
protective factors scores. The results for this analysis provide evidence that the youngest
age group may not have benefitted as much as the other age groups with increasing
protective factors for sobriety and maintaining a recovery-oriented outlook. However,
these results should be approached with caution due to the unacceptable reliability
measure of the BAM discharge scores, which is discussed in the limitations section.
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Relating the Results to Previous Literature
The variable of age differences in outcomes from treatment participation,
similarly to length of stay, was also not fully investigated in the literature. In a study
completed by Morse et al. (2015), results indicated that older adults typically stayed in
treatment for a significantly shorter timeframe, but also for that particular study, older
individuals tended to have more significant psychiatric concerns. However, the authors
(Morse et al., 2015) noted the possibility of these individuals placing greater perceived
importance on their mental health in contrast to the younger participants, which may have
led to increased motivation to stabilize their mental health. While not specifically
investigated in this study, it may be interesting and informative to examine trends among
the lengths of stay as they relate to the older versus younger participants. For example, a
question that could be investigated is whether older veterans stay a shorter or longer
amount of time than younger veterans.
There are many goals that are identified by veterans who participate in MH
RRTP, with decreasing symptoms of depression and anxiety while increasing ability to
maintain sobriety and a recovery-lifestyle often being cited. While these results were
somewhat unexpected, it is actually a testament to the effectiveness of the program and
evidence that MH RRTP participation may significantly impact outcomes on the BDI-II,
BAI, and BAM protective factors. This provides support for a conclusion that symptom
reduction is likely for veterans who participate in MH RRTP regardless of their age or
how long they remained in the program. It also provides evidence that the integrated
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treatment model, the service delivery primarily used in MH RRTP, provides effective
overall care for individuals in a VA residential treatment facility.
Limitations of the Study
There were general limitations to external validity in this study. These primarily
included lack of generalizability to the larger population. The results of this study only
apply to veterans with co-occurring disorders who participate in residential treatment
within the VA system. Because this study used a descriptive quantitative retrospective
design, a true cause and effect could not be established, as it was not possible to
manipulate the variables in this study or use a control group. While the study does not
allow for overall generalizability to the entire population, it can provide key information
about the program’s effectiveness for the veterans who have participated in it.
A key limitation of this exploratory study relates to its lack of examination of
long-term treatment outcomes of MH RRTP, as it instead focused specifically on
treatment impact at program completion. It is widely understood and accepted that
relapse is part of recovery (Decker et al., 2017) and MH RRTP participation is not
immune to this phenomenon. Unfortunately, there are some veterans who tend to cycle
through the program, doing well while there but then relapsing shortly after completion.
However, there are also those individuals who have reported long-term maintenance with
both their substance abuse and mental health disorders. It may be beneficial to explore
differences in types of aftercare involvement among individuals who maintain long-term
sobriety versus those who do not. Another limitation surrounds the unacceptable
reliability score of the BAM protective factors (discharge scores). This was in contrast to
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the reliability of the admission BAM scores, which rated as acceptable. However,
because this instrument has been used and validated in prior studies (Cacciola et al.,
2013; Nelson et al., 2014) and is a very common instrument within the VA system, it was
still used as an outcome measurement in this study. Additionally, there was the risk of
attrition bias (Salkind, 2010), in that results did not account for individuals who did not
complete both the pretest and posttest for the depression, anxiety, and substance abuse
measures. Finally, a limitation that should be considered relates to the potential of
depression symptoms decreasing due to duration of sustained abstinence during
residential treatment. This has been studied in previous research, including via a metaanalysis of 22 studies from 1980 to 2014 (Foulds, Adamson, Boden, Williman, &
Mulder, 2015). While there is sometimes an increase in depression symptoms during
early withdrawal, this meta-analysis demonstrated that there may be a correlation
between symptoms and duration of sobriety, often during the first 3 to 6 weeks of
treatment (Foulds et al., 2015).
Recommendations
While treatment for co-occurring disorders within the MH RRTP demonstrated a
decrease in depression and anxiety overall, in addition to an increase in protective factors,
there is a concern regarding long-term benefits and the rate of readmission for some
veterans. Notably, there are many veterans who maintain sobriety and recovery, while
others struggle with long-term outcomes. This predicament is not unique to veterans;
civilians certainly have similar difficulties with long-term recovery. While veterans are
encouraged to use their coping mechanisms that they have learned or reviewed in MH
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RRTP prior to consideration for readmission (such as within an outpatient program), if
they are not able to do this successfully, they will likely be readmitted to the residential
program. It is recommended that future studies look at long-term sobriety and recovery
following MH RRTP completion via a longitudinal approach, to determine if and where
there may be a lack of continuity in maintaining use of coping mechanisms. An aspect of
this has been implemented in MH RRTP but perhaps could be addressed even further.
Since 2011, follow-up surveys have been sent to veterans who completed MH RRTP to
determine, via self-report, if they have maintained sobriety and overall mental health
stability. During 2016, approximately 14% (156 individuals) completed and returned the
surveys, and during 2017, approximately 19% (133 individuals) returned their surveys.
For the 2016 data, 64 individuals reported maintaining sobriety and 142 reported that
their mental health was the same or better than at discharge from MH RRTP. For the
2017 data, 57 veterans reported maintaining sobriety and 121 reported their mental health
as the same or better since discharge.
While the importance of aftercare is undoubtedly stressed by the staff of MH
RRTP, sometimes veterans do not follow the recommendations. The structure that they
received while in residential programming can be difficult to maintain after discharge,
which may lead to difficulty maintaining sobriety on a long-term basis. It would also be
beneficial to complete a study looking at potential differences between graduating MH
RRTP veterans who participate in an outpatient program through the VA or in the
community following MH RRTP and veterans who do not attend the outpatient program.
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Future studies may also look at reasons for veterans not completing the posttest
questionnaires, as this decreased the number of valid participant scores. Veterans may
have preferred not to answer the questions, missed the outcome group (completed close
to admission and again at discharge), or left the program due to an irregular discharge.
Additionally, it may be useful to examine differences in outcomes between veterans who
attend community support groups following residential treatment and those who do not.
There are numerous other potential studies that could be pursued for MH RRTP,
including an investigation of outcomes based on the intensity of the program rather than
the length of stay by identifying the number and types of groups attended, whether
individual therapy was included with the traditional group therapies offered, and
involvement in other therapeutic activities, such as yoga or tai chi. Another possibility is
examining differences in outcomes for males versus females, particularly as the number
of female veterans continues to grow. Historically, the VA has been focused more on
male veterans, but over the past two decades, there have been gradual changes made to
address female veterans, including changes in MH RRTP. Additional potential studies
might also examine differences in outcomes for those who attend specific elective
groups. While examining the elective groups outcomes is done on a more informal basis
within MH RRTP, it may be useful to do this on a more formal level as the information
could be beneficial for other residential treatment programs in the VA system. Finally,
based on previous written information noted on the perceptions of care form and in
discussions with MH RRTP participants, it may be worthwhile to pursue a qualitative
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study by using veteran interviews and discuss veterans’ specific perceptions on whether
or not the program was helpful for them.
Implications
The implications of this study demonstrate overall that the residential treatment
program at the Saint Cloud VA and utilization of the integrated treatment model, which
offers an individualized and strengths-based approach, is effective for the treatment of
co-occurring disorders among the veteran population. Additionally, the results from the
current study support evidence for the use of CBT and MI, key components of the
integrated treatment model, as core interventions in a residential program to reduce
depression and anxiety symptoms. It also indicates, like previous studies, that overall
length of stay has very little impact on the extent of symptom reduction (Harris et al.,
2011), and that there are very few differences between age groups in symptom reduction.
Overall, regardless of how long veterans participated in the program and their age at time
of treatment, there was a consistent symptom reduction for anxiety and depression and an
overall increase in protective factors. Because the implications demonstrate success of
this treatment approach as evidenced by a decrease in scores overall from admission to
discharge, there is increased validity for utilizing this model for other VA residential
programs.
Implications for social change surround the need for veterans to have effective
care to address co-occurring disorders that is also time and cost-efficient. Many of the
MH RRTP veterans have jobs and/or other responsibilities that are impacted if they are
away from their homes for an extended amount of time. Since several other VA facilities
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are replicating this program, the continuing need for quality care for veterans with cooccurring disorders throughout the United States is being proactively addressed.
Conclusion
This study sought to examine outcomes based on use of the integrated treatment
model in the MH RRTP. Secondary data that included self-report scores collected at the
beginning and end of treatment, from the Beck Depression Inventory-II, Beck Anxiety
Inventory, and Brief Addiction Monitor, were compared to determine effectiveness of the
service delivery model of MH RRTP. Comparisons in outcomes were made for veterans
who participated in a brief treatment episode of care (33 days or less), a moderate time
frame (34-46 days), and a longer program (47 or more days). An additional component of
the study was to examine potential outcome differences among age groups. While the
overall results did not indicate a major influence on the length of stay towards the
depression, anxiety, and protective factors outcomes, there was a strong indication that
participation in the Saint Cloud MH RRTP did impact significant reductions in anxiety
and depression, while also improving protective factors to maintain sobriety and good
mental health. This study has provided crucial information that will be beneficial for
residential treatment interventions in the VA system. It will also impact future research
that seeks to examine outcomes related to specific interventions within MH RRTP,
detecting differences in outcomes between males and females, and long-term prognosis
for participants of the program. Most importantly, this study demonstrated the importance
of effective care for veterans diagnosed with mental health and substance abuse disorders
as they surely deserve the best care possible.
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Appendix B: Permission to Use BAM
From: DePhilippis, Dominick
Sent: Tuesday, February 27, 2018 10:09 AM (ET)
To: Hohenstern, Kathrin M.
Subject: RE: permission to use BAM
Thanks for consulting with me about the BAM.
The BAM and all the supporting materials created by the CESATE are in the public
domain; so, there are no licensing or copyright concerns.
All we ask is that you cite the CESATE.
I will send you an email with extensive BAM guidance and support materials.
From: Hohenstern, Kathrin M.
Sent: Tuesday, February 27, 2018 11:00 AM (CT)
To: DePhilippis, Dominick
Subject: permission to use BAM
Greetings from Saint Cloud, Minnesota. I am a clinical social worker at the VA in St.
Cloud and am completing a dissertation/study of our Mental Health Residential
Rehabilitation Treatment Program as part of my PhD social work degree and in
collaboration with the VA where I work. The program uses the BAM as a pre and post
measurement of the impact of treatment. I plan to use secondary data that has already
been gathered and is currently stored per VA protocol. I am nearing completion of my
proposal and am seeking permission to reproduce the questions in my proposal and
dissertation. I believe inclusion of the questions will provide the reader a greater
understanding of this instrument. Would you be willing to provide me permission to do
this? Thank you for your consideration.
Respectfully,
Kathrin Hohenstern, MSW, LICSW
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Appendix C: Permission to Use BAI and BDI-II
From: Licensing
Sent: Monday, March 5, 2018 11:37 AM
To: [Email address redacted]
Subject: Re: Permissions Request
Dear Ms Hohenstern,
This response is for both of your requests - the BDI-II and BAI.
Permission to use a Pearson assessment is inherent in the qualified purchase of the test
materials in sufficient quantity to meet your research goals. In any event, Pearson has no
objection to you using the Beck Depression Inventory®-II (BDI®-II) and the Beck
Anxiety Inventory® (BAI®) and you may take this email response as formal permission
from Pearson to use the tests in their as-published formats in your student research upon
purchase qualification.
The BDI-II and BAI are sensitive clinical assessments that require a high degree of
qualification (B Level) to purchase, administer, score and interpret. They also represent
Pearson copyright and trade secret material. As such, Pearson does not permit
photocopying or other reproduction of our test materials by any means and for any
purpose when they are readily available in our catalog. Consequently, you may not
simply reproduce or further adapt the BDI-II and BAI test forms.
Long term license agreements with our Test Authors prohibit Pearson from providing or
licensing our test materials at no charge/gratis for any purpose.
If you do not yet meet the qualifications to purchase the test materials, your professor or
faculty supervisor may be able to assist you by lending their qualifications.
The following links to the product pages in our online catalog are:
For the BDI-II: https://www.pearsonclinical.com/psychology/products/100000159/beckdepression-inventoryii-bdi-ii.html?origsearchtext=100000159
For the BAI: https://www.pearsonclinical.com/psychology/products/100000251/beckanxiety-inventory-bai.html
Finally, because of test security concerns, permission is not granted for appending tests to
theses, dissertations, or reports of any kind. You may not include any actual assessment
test items, discussion of any actual test items or inclusion of the actual assessment
product in the body or appendix of your dissertation or thesis. You are only permitted to
describe the test, its function and how it is administered; and discuss the fact that you
used the Test, your analysis, summary statistics, and the results.
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That said, we have prepared a few sample test items that you may include in your
research results and I have attached them herein for your possible use.
Regards,
William H. Schryver
Senior Legal Licensing Specialist
Please respond only to pas.licensing@pearson.com

